data_2ley_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ley _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.4 mt . . . . . 0 CA--C 1.519 -0.218 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.25 140.61 50.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.75 156.06 30.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.4 m -79.58 115.11 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.295 0.569 . . . . 0.0 111.164 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.6 145.83 28.03 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.566 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HG2' ' CZ ' ' A' ' 25' ' ' PHE . 36.1 mtmm -90.58 115.58 27.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.28 -47.73 2.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.012 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -174.22 153.31 1.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.725 0.262 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.501 ' SG ' HD11 ' A' ' 26' ' ' LEU . 5.4 m -78.31 163.29 25.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 1.1 ptmm? -106.56 170.58 7.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -49.52 135.23 18.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.355 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.47 20.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.132 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.839 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 57.5 mt-10 -95.18 136.53 35.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.931 0.396 . . . . 0.0 111.367 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -103.36 128.06 50.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.13 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 26' ' ' LEU . 7.5 p -73.3 138.2 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.69 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 79.6 mtp180 -135.84 38.69 2.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.96 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.13 -148.16 17.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.863 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 11.9 p -134.75 157.53 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.35 0.26 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 p -154.41 46.22 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.744 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.96 165.36 14.38 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 pt -64.59 112.27 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.119 0.459 . . . . 0.0 109.765 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 67.21 18.35 10.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 2.8 m-85 -115.18 136.92 52.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.838 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 pt? -121.36 155.38 34.9 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.251 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.72 121.07 24.27 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.5 m -121.29 128.54 52.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.69 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 75.0 m -124.38 98.03 38.83 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.839 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 74.1 Cg_endo . . . . . 0 N--CA 1.46 -0.448 0 C-N-CA 122.994 2.462 . . . . 0.0 112.911 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.83 144.42 30.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.79 165.61 34.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.56 118.9 24.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.172 0.511 . . . . 0.0 112.12 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.93 143.85 19.95 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.7 110.44 16.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.665 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 24' ' ' ARG . . . 75.88 -41.36 1.47 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.793 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -170.36 159.89 7.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.174 0.487 . . . . 0.0 110.72 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.603 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 22.4 m -79.07 162.66 25.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -83.54 153.05 24.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -66.25 74.59 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.491 0.662 . . . . 0.0 111.164 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 -30.05 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.603 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 13.4 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -111.02 141.72 44.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.888 0.375 . . . . 0.0 111.336 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG13 ' SG ' ' A' ' 11' ' ' CYS . 29.2 m -64.53 138.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.405 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -113.54 -31.13 6.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.31 -144.56 8.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.8 p -132.49 141.13 48.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.723 0.261 . . . . 0.0 110.406 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 75.0 m -96.53 -38.85 9.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.883 0.373 . . . . 0.0 110.736 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.95 -150.65 11.98 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.912 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.55 113.6 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.244 0.545 . . . . 0.0 111.558 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 9' ' ' GLY . 6.1 tpm_? 62.7 19.78 11.62 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.885 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 7.6 m-85 -122.9 134.54 54.36 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.631 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.8 mp -125.57 144.52 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.298 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.61 127.69 33.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 m -129.44 146.74 51.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.706 0.289 . . . . 0.0 111.367 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 57.6 m -136.84 115.12 10.26 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 14.1 Cg_exo . . . . . 0 C--O 1.234 0.299 0 C-N-CA 123.062 2.508 . . . . 0.0 112.266 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 3' ' ' LEU . 98.2 mt . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -75.43 142.07 43.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.845 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.407 ' HH ' ' CD ' ' A' ' 15' ' ' GLU . 23.9 p90 -149.71 160.22 43.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.967 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -79.7 108.75 13.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.96 0.41 . . . . 0.0 111.192 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.85 140.88 24.66 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -90.2 115.65 27.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 110.521 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.1 -43.66 2.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.493 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -173.5 155.23 2.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.027 0.413 . . . . 0.0 110.761 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 15.7 m -78.34 164.15 25.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.622 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -78.93 150.57 32.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.638 0.256 . . . . 0.0 110.389 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -64.98 74.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.941 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.39 -29.99 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 16.1 pt-20 -96.44 -173.58 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 16' ' ' ARG . 3.4 ptp85 -131.8 142.87 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.901 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG21 ' N ' ' A' ' 18' ' ' ARG . 7.4 p -78.59 143.0 13.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.422 ' N ' HG21 ' A' ' 17' ' ' VAL . 60.6 ttp85 -150.55 39.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.874 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.5 29.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.593 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.6 p -141.83 144.25 33.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.6 m -119.08 37.48 4.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 111.171 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 -173.39 22.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.115 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 23' ' ' ILE . 20.5 pt -61.2 119.2 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.833 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 70.39 24.29 4.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.685 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 51.7 m-85 -139.5 140.93 37.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.2 pt? -144.8 152.62 40.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.62 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 124.83 28.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -121.79 142.41 50.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.882 0.373 . . . . 0.0 111.065 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 39.8 m -135.35 118.3 12.71 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.699 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo . . . . . 0 CA--C 1.533 0.459 0 C-N-CA 123.527 2.818 . . . . 0.0 114.229 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.503 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 3.6 mm? . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.735 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 17.9 m -71.51 141.79 50.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -128.59 158.47 38.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.418 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.4 m -82.16 106.6 14.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.071 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.77 137.45 22.39 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -82.11 117.88 22.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.6 2.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.668 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 179.74 146.64 0.22 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.788 0.294 . . . . 0.0 110.578 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 32.0 m -79.87 -176.14 5.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HZ2' ' CD ' ' A' ' 15' ' ' GLU . 1.3 pptp? -151.46 -170.4 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 -64.65 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.75 -33.23 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 1.3 pm0 -125.35 153.12 43.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.49 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.11 122.38 40.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.898 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 p -69.66 136.22 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.735 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 83.7 mtp180 -126.63 -28.29 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.558 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.68 -159.69 23.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.891 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.7 p -108.54 141.35 40.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.614 0.245 . . . . 0.0 110.9 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.4 t -89.11 -42.84 11.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.179 0.514 . . . . 0.0 109.973 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.6 -156.28 20.5 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.427 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 18.3 pt -62.75 113.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.134 0.493 . . . . 0.0 111.008 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 66.12 26.71 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.383 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 38.4 m-85 -137.22 137.41 39.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.253 0.549 . . . . 0.0 110.957 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 26' ' ' LEU . 8.7 mp -114.84 148.47 38.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.88 113.17 25.18 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 51.0 m -138.3 140.17 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.731 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 32.7 m -95.11 114.68 64.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.307 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 64.5 Cg_endo . . . . . 0 C--O 1.234 0.311 0 C-N-CA 123.134 2.556 . . . . 0.0 112.716 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.686 0.279 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.8 m -55.74 140.61 41.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.14 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -155.11 154.66 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.2 m -78.75 105.59 10.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.087 0.47 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.88 140.82 32.05 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -82.59 116.42 21.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.16 -41.82 2.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.805 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.21 165.21 2.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.776 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 9.6 m -78.33 166.41 22.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 4.6 tppt? -78.45 145.4 35.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -68.39 71.09 0.18 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.64 0.734 . . . . 0.0 110.341 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.06 -29.76 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.047 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 14.1 pt-20 -90.16 178.94 6.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.625 0.25 . . . . 0.0 110.975 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -110.4 134.16 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.022 0.439 . . . . 0.0 111.397 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.12 146.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.767 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 mmt85 -119.77 -41.88 2.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.13 -142.24 6.76 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.7 p -127.24 139.99 52.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.008 0.404 . . . . 0.0 111.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -93.3 -38.12 11.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.99 -154.16 18.81 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.0 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -61.77 116.28 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.219 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 44.4 ttp180 64.06 24.55 13.56 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.399 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.07 136.12 36.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 111.068 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.4 mp -128.89 147.81 50.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.388 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.47 122.82 27.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.6 m -132.97 155.37 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.486 0.184 . . . . 0.0 111.123 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.403 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 60.9 m -139.11 113.62 8.25 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.323 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 18.4 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 123.224 2.616 . . . . 0.0 113.058 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 3' ' ' LEU . 3.2 mm? . . . . . 0 CA--C 1.521 -0.171 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -68.91 141.01 55.13 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.401 0.438 . . . . 0.0 111.484 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.56 153.95 32.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.658 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.03 116.16 20.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 112.159 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.61 148.53 23.83 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -90.08 122.01 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.826 0.346 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.88 -43.27 1.92 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.576 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -174.9 157.1 2.34 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.257 0.529 . . . . 0.0 111.013 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.566 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 58.3 m -79.06 163.51 25.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.373 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 35.0 mtmm -86.52 147.52 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.251 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -63.82 82.62 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.434 0.635 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.48 -33.06 0.16 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 5.5 pt-20 -96.67 154.88 17.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.802 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.32 141.86 34.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 HD21 ' A' ' 26' ' ' LEU . 35.4 m -69.75 143.39 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.509 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -48.04 2.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.562 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.77 -174.95 46.46 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 p -89.64 139.51 30.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.562 0.681 . . . . 0.0 111.283 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 96.2 m -97.84 -42.56 7.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.144 0.497 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.26 -156.17 23.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.447 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 pt -62.19 112.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.212 0.53 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 66.13 24.56 10.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.742 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 17.9 m-85 -130.14 136.19 49.02 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 17' ' ' VAL . 20.4 tp -132.58 137.96 47.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 119.16 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.37 139.69 50.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.73 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 82.3 m -124.19 103.59 32.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.782 0.325 . . . . 0.0 110.603 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.831 2.354 . . . . 0.0 111.418 179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.954 0.407 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.0 m -76.15 141.99 41.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.678 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.25 166.26 33.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.714 0.292 . . . . 0.0 110.596 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 47.7 t -79.56 118.61 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.571 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 138.29 13.9 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.626 ' HB3' ' HZ1' ' A' ' 8' ' ' LYS . 7.8 mtpm? -91.16 118.22 30.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.544 0.211 . . . . 0.0 110.927 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.49 -44.74 2.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.479 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.408 ' HA ' HD23 ' A' ' 26' ' ' LEU . 28.5 p80 -172.39 157.73 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.959 0.38 . . . . 0.0 110.422 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 35.5 m -78.4 164.76 24.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -87.62 152.79 21.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -52.15 116.91 2.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.916 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.38 -26.18 7.86 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.845 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 1.099 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 76.5 mt-10 -85.69 136.37 33.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.622 -0.289 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -100.31 131.37 46.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.668 HG23 HD11 ' A' ' 26' ' ' LEU . 6.5 p -65.86 129.12 29.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 110.505 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.8 tmm_? -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.527 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -156.64 25.4 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.928 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -89.11 150.7 22.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.795 0.331 . . . . 0.0 111.494 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.1 t -119.7 -41.83 2.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.71 -156.74 18.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -65.58 111.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.388 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' C ' ' HD1' ' A' ' 25' ' ' PHE . 62.5 mmt-85 62.0 22.67 13.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.438 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' HD1' ' C ' ' A' ' 24' ' ' ARG . 4.7 m-30 -122.92 142.23 51.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.672 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 17' ' ' VAL . 2.5 pt? -139.1 148.95 43.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HD2' ' HE ' ' A' ' 18' ' ' ARG . 1.9 t80 -79.58 126.42 30.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.6 m -117.82 136.93 53.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.758 0.313 . . . . 0.0 111.23 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.3 92.92 47.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.349 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.099 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 42.5 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 122.595 2.197 . . . . 0.0 112.794 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.58 HD22 ' HG2' ' A' ' 30' ' ' PRO . 54.6 tp . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.93 144.02 16.06 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -160.54 162.53 32.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 15.2 t -86.02 119.93 26.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.176 0.512 . . . . 0.0 111.592 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.09 135.45 13.22 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -87.24 118.41 26.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.46 1.87 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -171.36 157.21 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 17' ' ' VAL . 60.1 m -78.49 169.94 17.45 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.489 0.493 . . . . 0.0 110.362 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 28.2 ttmt -78.77 141.34 37.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -61.31 90.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.03 -35.73 0.72 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 5.1 pt-20 -88.3 172.11 9.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.85 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -118.84 144.6 46.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG12 ' SG ' ' A' ' 11' ' ' CYS . 28.5 m -69.02 138.48 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD3' ' CD2' ' A' ' 27' ' ' TYR . 80.5 ttt180 -115.68 -28.28 6.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.413 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.84 -154.08 15.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 16.1 p -132.27 140.68 48.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.745 0.273 . . . . 0.0 110.641 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 4.6 m -93.14 -37.88 11.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.183 0.516 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.07 -152.21 13.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.585 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.21 114.93 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.125 0.488 . . . . 0.0 111.283 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 64.94 22.97 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.607 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 7.9 m-85 -128.67 134.63 48.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.497 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 6.7 mp -133.6 142.72 48.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.982 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 18' ' ' ARG . 2.7 t80 -81.52 129.5 34.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 m -129.33 147.08 51.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.021 0.439 . . . . 0.0 111.63 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 74.9 m -135.02 118.22 13.01 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.58 ' HG2' HD22 ' A' ' 3' ' ' LEU . 18.3 Cg_exo . . . . . 0 C--O 1.233 0.259 0 C-N-CA 123.192 2.594 . . . . 0.0 113.623 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 3' ' ' LEU . 6.9 mp . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 121.064 0.459 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 87.3 m -76.3 141.57 41.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.56 157.11 29.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.9 m -80.36 113.64 18.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.085 0.469 . . . . 0.0 110.961 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.03 144.03 25.78 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.504 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -86.12 113.49 22.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 110.966 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.37 -40.28 1.28 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.636 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -170.36 156.67 5.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.001 0.401 . . . . 0.0 110.552 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.557 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 30.9 m -78.48 162.18 26.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.846 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.2 mtmp? -81.54 141.38 33.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.723 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -54.51 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.96 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.79 -41.65 0.69 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 7.9 pt-20 -87.82 -176.31 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 110.973 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -132.63 144.78 50.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 111.304 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 26' ' ' LEU . 25.1 t -73.3 139.5 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 32.1 mmt180 -118.77 -31.51 4.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.11 -143.62 5.84 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.828 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.737 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.3 p -136.62 148.26 47.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.647 0.224 . . . . 0.0 110.409 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -160.27 98.33 1.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 151.45 24.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.709 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.703 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 20.0 pt -59.0 122.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.663 0.231 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 14.2 ptt-85 61.93 24.4 14.52 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.549 1.14 . . . . 0.0 111.734 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.11 140.37 52.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.926 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.3 pt? -126.39 153.06 45.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.442 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.15 121.8 24.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.19 139.37 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.852 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.8 m -133.11 124.94 18.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--O 1.233 0.252 0 C-N-CA 123.045 2.497 . . . . 0.0 112.709 -179.522 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.6 m -150.66 143.29 24.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.86 160.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.096 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.8 m -88.05 110.64 20.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.996 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.57 134.76 15.11 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.59 118.48 23.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 110.23 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA2' ' HG3' ' A' ' 24' ' ' ARG . . . 79.64 -41.2 2.31 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -175.09 144.68 0.76 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.765 0.282 . . . . 0.0 110.788 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.603 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 58.0 m -84.95 -178.54 6.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -81.69 142.43 32.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -64.15 86.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.289 0.566 . . . . 0.0 111.166 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.83 -19.07 0.57 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.603 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 83.5 mt-10 -78.48 148.31 33.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -85.24 115.54 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.62 HG22 HD22 ' A' ' 26' ' ' LEU . 4.2 p -74.0 138.57 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.9 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.617 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 55.9 mtp85 -115.09 -43.56 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.785 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.88 -171.48 43.38 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.682 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 p -88.91 143.86 26.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.017 0.409 . . . . 0.0 110.899 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.8 p -145.39 44.4 1.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.0 111.735 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.62 168.63 13.75 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 pt -63.91 109.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 110.098 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG3' ' HA2' ' A' ' 9' ' ' GLY . 11.0 tpt180 65.3 26.99 12.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.874 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 5.5 m-85 -113.15 135.12 54.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.182 0.515 . . . . 0.0 110.158 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD22 HG22 ' A' ' 17' ' ' VAL . 20.7 tp -121.16 125.74 47.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.744 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 t80 -79.03 119.58 22.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -137.18 142.3 42.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 111.222 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 76.8 m -103.37 104.7 42.77 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 72.0 Cg_endo . . . . . 0 N--CA 1.453 -0.911 0 C-N-CA 122.574 2.183 . . . . 0.0 114.574 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.969 0.414 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.2 m -78.69 137.38 37.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.84 160.27 27.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -80.52 117.16 21.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.193 0.521 . . . . 0.0 112.157 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.29 139.69 14.89 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.09 129.0 37.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.025 0.44 . . . . 0.0 110.023 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -48.56 3.88 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.449 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.0 p80 179.27 160.4 0.72 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.801 0.3 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 163.18 25.68 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -94.14 153.25 18.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -49.71 108.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.09 -27.05 4.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.429 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 1.05 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 94.8 mt-10 -87.71 135.55 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.835 0.35 . . . . 0.0 110.613 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -91.94 125.76 36.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.25 134.98 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -110.61 -34.83 6.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.131 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.09 -152.48 14.87 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.4 p -118.62 138.8 52.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.047 0.424 . . . . 0.0 111.144 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -93.01 -37.13 12.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 110.279 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.02 14.84 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.63 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.452 HD11 HG21 ' A' ' 23' ' ' ILE . 17.0 pt -61.48 114.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 111.504 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 63.44 21.78 12.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.723 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.94 136.64 51.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.146 0.498 . . . . 0.0 111.086 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.0 mp -128.54 147.2 50.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.353 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.95 122.84 27.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.48 136.46 54.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.976 0.417 . . . . 0.0 111.667 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 90.9 m -129.43 96.78 26.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.05 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 32.2 Cg_endo . . . . . 0 N--CA 1.464 -0.228 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.837 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.958 0.409 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.07 150.68 43.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.189 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.87 167.75 28.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.958 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 72.0 m -79.52 104.6 10.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.41 -178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.78 26.89 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.69 108.37 17.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.8 -40.71 1.4 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.43 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -167.67 163.61 14.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 32.2 m -78.46 161.3 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.463 . . . . 0.0 110.522 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.51 157.94 15.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.265 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -52.52 120.32 5.48 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.04 10.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.524 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 1.067 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 78.5 mt-10 -86.49 130.73 34.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.708 0.289 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.39 121.65 39.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.27 132.26 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -102.6 -43.37 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.113 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.41 -135.38 3.66 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -89.55 139.84 30.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.981 0.391 . . . . 0.0 110.823 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.21 -42.56 5.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.254 0.55 . . . . 0.0 110.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.75 21.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 pt -62.04 110.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.288 0.566 . . . . 0.0 110.912 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 59.87 27.97 17.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.199 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 25.9 m-85 -123.81 138.29 54.53 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -99.66 136.7 39.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.806 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.05 114.31 19.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.1 m -123.22 135.78 54.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 111.739 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 m -128.57 100.61 21.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.197 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.067 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 43.4 Cg_endo . . . . . 0 N--CA 1.463 -0.277 0 C-N-CA 122.539 2.159 . . . . 0.0 113.646 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.302 0.572 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 56.6 m -67.38 139.84 57.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.017 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.01 174.88 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 95.6 m -83.07 112.54 19.89 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.51 130.87 9.99 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 10' ' ' HIS . 37.2 mtmm -74.4 101.39 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.35 . . . . 0.0 111.633 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.12 -32.62 0.93 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.718 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.415 ' H ' ' C ' ' A' ' 8' ' ' LYS . 19.0 p-80 -167.15 151.56 6.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.928 0.364 . . . . 0.0 110.338 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.518 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 63.5 m -79.57 166.05 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.936 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 12' ' ' LYS . 1.7 ttmp? -79.39 145.53 33.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.612 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -64.98 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.33 0.586 . . . . 0.0 111.341 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.12 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.489 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 28' ' ' CYS . 1.7 pt-20 -99.32 157.35 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 111.271 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -93.63 137.13 33.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.875 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -82.69 118.94 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 46.0 tpt85 -89.94 -35.92 15.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.663 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.25 -137.22 4.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.678 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -90.88 142.35 27.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.52 0.2 . . . . 0.0 110.959 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -113.0 -40.64 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.127 0.489 . . . . 0.0 109.884 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.33 -157.85 17.71 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.5 111.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 58.61 26.77 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.877 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 24.1 m-85 -124.04 137.3 54.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 26' ' ' LEU . 9.2 mp -105.5 145.93 30.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.021 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -79.44 108.72 13.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 12.8 m -110.03 131.61 54.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.382 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -122.77 106.81 34.18 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 35.4 Cg_endo . . . . . 0 C--O 1.234 0.283 0 C-N-CA 123.148 2.565 . . . . 0.0 113.597 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.589 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 5.0 tt . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.43 147.24 28.03 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.0 155.68 29.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.794 0.33 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.77 107.07 16.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.944 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.04 139.27 24.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -89.92 117.13 28.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.45 -43.78 2.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -165.68 146.75 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 61.7 m -86.49 -163.85 0.96 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.602 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -79.85 149.89 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.624 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -67.25 117.78 9.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 1.07 60.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.035 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.646 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 5.5 tt0 -78.7 149.21 32.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.6 mmm-85 -98.23 121.1 39.75 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.549 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.4 138.11 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -111.45 -39.88 4.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.578 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.7 178.61 44.71 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -89.23 138.97 30.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.158 0.479 . . . . 0.0 110.891 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 67.7 m -92.76 -39.09 11.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.071 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.8 -154.92 19.78 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 23' ' ' ILE . 16.6 pt -62.1 113.88 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.199 0.524 . . . . 0.0 111.233 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 64.57 21.47 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.725 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.673 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 3.8 m-85 -121.54 134.87 55.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.029 0.442 . . . . 0.0 111.006 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -131.98 128.25 38.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.661 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.429 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 t80 -81.99 120.26 25.03 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 79.0 m -135.27 150.87 50.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 111.403 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.9 m -124.15 115.72 27.4 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.546 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 59.0 Cg_endo . . . . . 0 N--CA 1.457 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 113.847 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.819 0.343 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 62.9 m -56.68 137.05 54.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.634 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.95 164.44 34.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.4 t -79.36 103.4 9.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.798 0.332 . . . . 0.0 111.018 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.11 136.15 19.04 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -91.89 115.88 28.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.73 0.3 . . . . 0.0 111.096 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.76 -43.48 1.65 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.088 -0.577 . . . . 0.0 114.338 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -172.49 148.84 2.06 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.519 0.659 . . . . 0.0 111.317 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.4 m -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.457 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 56.5 tptt -79.17 134.94 36.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.398 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -58.38 97.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.941 0.4 . . . . 0.0 110.239 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.36 0.67 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.729 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 15.9 pt-20 -86.86 167.38 14.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -112.39 133.97 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.667 HG12 HD12 ' A' ' 26' ' ' LEU . 36.3 t -73.11 131.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.102 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HD2' ' HD2' ' A' ' 27' ' ' TYR . 58.9 ttm-85 -93.13 -38.03 11.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.918 0.389 . . . . 0.0 110.174 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.76 -160.64 28.07 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -89.71 142.81 27.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.743 0.306 . . . . 0.0 111.506 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.9 t -104.46 -42.65 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.031 0.443 . . . . 0.0 110.09 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.83 -152.53 11.38 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 pt -63.9 110.57 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 59.89 25.75 14.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.08 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.11 142.57 51.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.745 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.667 HD12 HG12 ' A' ' 17' ' ' VAL . 2.2 pt? -140.52 147.9 40.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.583 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 1.2 t80 -79.9 121.73 25.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 17.3 m -113.14 143.04 45.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.931 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -127.37 103.61 22.55 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.74 0.305 . . . . 0.0 110.242 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.729 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 42.0 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 123.186 2.59 . . . . 0.0 112.41 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.646 0.26 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.49 145.5 55.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.281 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.4 165.79 33.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 93.5 m -85.79 106.67 17.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.941 0.4 . . . . 0.0 110.845 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -72.33 151.58 46.98 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.765 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -86.35 92.17 8.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.73 -38.61 1.93 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.213 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -155.29 149.22 25.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.53 ' SG ' HG11 ' A' ' 17' ' ' VAL . 25.1 m -79.2 179.69 7.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -79.49 140.0 37.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -63.48 74.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.383 0.611 . . . . 0.0 111.845 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.75 -35.47 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.184 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 3.6 pt-20 -83.75 -178.33 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.881 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HD2' ' C ' ' A' ' 15' ' ' GLU . 1.4 mpt_? -125.5 140.78 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 111.322 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG11 ' SG ' ' A' ' 11' ' ' CYS . 33.7 m -72.3 149.74 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 28.2 mmm180 -125.68 -33.17 2.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.61 -151.93 10.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.604 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.1 p -129.39 141.41 51.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.838 0.319 . . . . 0.0 110.715 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.3 m -97.29 -38.27 9.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.628 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.21 -154.89 22.45 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.053 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 17.2 pt -61.57 112.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.444 0.64 . . . . 0.0 111.063 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.9 mmt-85 64.5 31.7 12.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.168 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.695 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 41.5 m-85 -140.86 136.78 32.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.153 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.7 pt? -143.91 151.26 39.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.74 123.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.8 m -124.54 139.31 53.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 95.1 m -127.27 115.4 21.58 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 6.0 Cg_exo . . . . . 0 N--CA 1.459 -0.53 0 C-N-CA 123.318 2.679 . . . . 0.0 111.441 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 3' ' ' LEU . 1.4 tm? . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 81.0 m -77.82 139.16 39.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.629 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -157.28 161.27 39.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.203 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 21.0 t -79.28 105.87 10.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.28 142.14 21.93 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.328 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -91.86 120.34 32.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.03 -52.27 2.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.385 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.32 155.28 0.5 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.202 0.501 . . . . 0.0 111.848 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.544 ' SG ' HD23 ' A' ' 26' ' ' LEU . 3.3 m -79.2 169.96 17.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.686 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.654 ' HG2' ' OE2' ' A' ' 15' ' ' GLU . 28.4 mmtt -81.61 160.85 23.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -66.84 72.19 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.006 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.39 -26.12 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.375 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.947 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.4 mt-10 -79.17 145.88 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.311 . . . . 0.0 110.384 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -83.62 125.62 32.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.69 HG22 HD21 ' A' ' 26' ' ' LEU . 3.7 p -76.47 132.96 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 27' ' ' TYR . 27.0 mmm180 -113.03 -44.69 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.452 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.38 -145.95 10.26 Favored Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.378 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -107.02 143.01 35.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.018 0.409 . . . . 0.0 110.683 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 7.8 p -122.14 11.14 10.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 111.057 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.93 -173.5 36.62 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 pt -65.28 114.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.388 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 63.18 23.67 14.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.964 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 22.7 m-30 -115.14 138.36 50.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.345 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.69 HD21 HG22 ' A' ' 17' ' ' VAL . 5.4 tt -122.51 136.17 54.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 2.7 t80 -78.13 117.76 19.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 57.1 m -109.05 140.72 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.029 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.26 80.33 19.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.947 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 19.7 Cg_endo . . . . . 0 C--O 1.233 0.235 0 C-N-CA 122.9 2.4 . . . . 0.0 112.635 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 48.7 m -66.14 137.45 57.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.591 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.94 160.82 40.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.789 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.41 118.32 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.078 0.466 . . . . 0.0 111.943 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.04 154.8 24.0 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.377 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.61 108.73 19.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 111.474 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.66 -40.32 0.95 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.95 154.03 17.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.068 0.434 . . . . 0.0 110.919 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' SG ' HD11 ' A' ' 26' ' ' LEU . 16.6 m -79.12 161.96 26.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.087 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HD3' ' OE2' ' A' ' 15' ' ' GLU . 1.6 tttt -80.19 152.8 28.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.703 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -52.99 132.24 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.052 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.49 24.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.59 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 21.9 mt-10 -82.36 149.59 27.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -108.67 129.52 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 p -66.75 130.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.26 0.553 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 7.8 tpm_? -97.07 -40.91 8.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.87 -160.77 33.4 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.784 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.5 p -89.57 143.11 27.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.946 0.373 . . . . 0.0 111.363 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 52.3 t -110.33 -41.25 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.969 0.414 . . . . 0.0 110.29 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.99 -157.69 23.89 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.8 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -64.16 109.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.5 0.667 . . . . 0.0 110.542 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 62.51 30.5 17.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.059 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.606 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 29.1 m-85 -131.52 139.42 49.27 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.499 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.525 HD21 ' N ' ' A' ' 26' ' ' LEU . 2.6 pt? -140.49 143.64 35.59 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.3 t80 -78.3 123.28 26.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 55.9 m -121.5 140.0 52.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.192 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -120.43 96.72 49.03 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 33.9 Cg_endo . . . . . 0 C--O 1.233 0.25 0 C-N-CA 122.732 2.288 . . . . 0.0 114.353 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 3' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.781 0.325 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.0 m -62.58 138.45 58.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.98 163.26 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 70.0 m -91.75 107.93 19.55 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.873 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 148.24 40.46 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.073 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -83.84 108.72 17.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.632 0.253 . . . . 0.0 110.395 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.17 -43.16 1.72 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.865 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.09 142.06 3.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.582 0.229 . . . . 0.0 110.518 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.5 m -84.08 174.29 10.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.2 142.16 34.96 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -60.32 109.13 0.92 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.36 -26.61 2.28 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 1.029 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 41.4 mt-10 -78.8 139.16 38.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.269 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -82.95 97.9 8.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.92 127.89 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -95.88 -39.68 9.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.485 . . . . 0.0 109.728 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.9 -153.92 23.13 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.546 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -88.87 140.0 29.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.72 0.295 . . . . 0.0 111.042 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.3 t -93.87 -42.69 8.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.287 0.565 . . . . 0.0 110.004 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.21 -152.41 14.6 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.401 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 16.9 pt -58.6 116.05 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.775 0.287 . . . . 0.0 110.323 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 15.4 ptm180 49.9 29.24 3.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 112.137 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 3.5 m-30 -122.45 137.89 54.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 21.7 tp -117.69 132.35 56.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.644 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.64 120.79 34.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 56.5 m -137.03 154.3 50.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.034 0.445 . . . . 0.0 111.724 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 81.4 m -123.52 91.68 49.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.558 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.029 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 29.2 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 C-N-CA 122.496 2.131 . . . . 0.0 112.661 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 32.5 m -60.93 138.91 58.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.063 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.75 157.31 43.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -85.97 115.48 23.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.468 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 11' ' ' CYS . . . -85.19 135.71 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -86.39 114.49 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.029 0.442 . . . . 0.0 110.38 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.52 3.69 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.061 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 179.58 137.58 0.11 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.397 . . . . 0.0 110.301 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 38.4 m -80.2 -154.47 0.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.593 ' HB2' ' OE2' ' A' ' 15' ' ' GLU . 10.1 mmpt? -106.39 152.31 23.76 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -68.36 63.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.799 0.809 . . . . 0.0 110.558 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.78 -35.77 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.371 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.901 ' HG3' ' HB3' ' A' ' 30' ' ' PRO . 2.4 mp0 -79.9 138.3 37.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.061 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.47 128.03 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 127.62 30.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.291 0.567 . . . . 0.0 110.606 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -103.36 -33.98 8.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.059 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.63 -152.78 20.4 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 14.1 p -116.43 139.74 50.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.848 0.324 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.1 m -92.57 -38.49 11.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.01 -153.99 14.16 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.793 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 23' ' ' ILE . 17.1 pt -59.25 113.06 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.57 . . . . 0.0 111.628 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 60.91 27.1 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.244 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.34 136.0 49.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.817 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.3 mp -125.48 142.02 51.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -83.75 121.48 27.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 70.1 m -127.17 135.04 50.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 111.689 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 72.9 m -110.15 104.21 55.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.769 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.901 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 72.8 Cg_endo . . . . . 0 C--O 1.232 0.217 0 C-N-CA 122.908 2.405 . . . . 0.0 114.038 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 tp -137.36 47.19 2.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.518 0.675 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.4 mt -139.7 131.17 26.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.675 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.25 140.61 50.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.75 156.06 30.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.4 m -79.58 115.11 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.295 0.569 . . . . 0.0 111.164 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.6 145.83 28.03 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.566 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HG2' ' CZ ' ' A' ' 25' ' ' PHE . 36.1 mtmm -90.58 115.58 27.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.28 -47.73 2.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.012 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -174.22 153.31 1.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.725 0.262 . . . . 0.0 110.359 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.501 ' SG ' HD11 ' A' ' 26' ' ' LEU . 5.4 m -78.31 163.29 25.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 1.1 ptmm? -106.56 170.58 7.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -49.52 135.23 18.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.355 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.47 20.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.132 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.839 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 57.5 mt-10 -95.18 136.53 35.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.931 0.396 . . . . 0.0 111.367 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -103.36 128.06 50.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.13 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 26' ' ' LEU . 7.5 p -73.3 138.2 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.69 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 79.6 mtp180 -135.84 38.69 2.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.96 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.13 -148.16 17.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.863 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 11.9 p -134.75 157.53 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.35 0.26 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 p -154.41 46.22 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.744 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.96 165.36 14.38 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 pt -64.59 112.27 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.119 0.459 . . . . 0.0 109.765 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 67.21 18.35 10.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 2.8 m-85 -115.18 136.92 52.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.838 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 pt? -121.36 155.38 34.9 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.251 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.72 121.07 24.27 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.5 m -121.29 128.54 52.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.69 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 75.0 m -124.38 98.03 38.83 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.839 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 74.1 Cg_endo -76.59 149.09 30.04 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.994 2.462 . . . . 0.0 112.911 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ptm85 -121.88 32.46 5.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.551 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.251 1.145 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.224 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.28 62.67 3.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.06 0.457 . . . . 0.0 110.575 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp -150.97 135.91 17.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.246 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.83 144.42 30.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.79 165.61 34.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.56 118.9 24.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.172 0.511 . . . . 0.0 112.12 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.93 143.85 19.95 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.7 110.44 16.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.665 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 24' ' ' ARG . . . 75.88 -41.36 1.47 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.793 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -170.36 159.89 7.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.174 0.487 . . . . 0.0 110.72 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.603 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 22.4 m -79.07 162.66 25.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -83.54 153.05 24.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -66.25 74.59 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.491 0.662 . . . . 0.0 111.164 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 -30.05 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.603 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 13.4 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -111.02 141.72 44.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.888 0.375 . . . . 0.0 111.336 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG13 ' SG ' ' A' ' 11' ' ' CYS . 29.2 m -64.53 138.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.405 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -113.54 -31.13 6.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.31 -144.56 8.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.8 p -132.49 141.13 48.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.723 0.261 . . . . 0.0 110.406 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 75.0 m -96.53 -38.85 9.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.883 0.373 . . . . 0.0 110.736 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.95 -150.65 11.98 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.912 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.55 113.6 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.244 0.545 . . . . 0.0 111.558 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 9' ' ' GLY . 6.1 tpm_? 62.7 19.78 11.62 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.885 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 7.6 m-85 -122.9 134.54 54.36 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.631 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.8 mp -125.57 144.52 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.298 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.61 127.69 33.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 m -129.44 146.74 51.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.706 0.289 . . . . 0.0 111.367 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 57.6 m -136.84 115.12 10.26 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 14.1 Cg_exo -69.34 144.51 56.51 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.062 2.508 . . . . 0.0 112.266 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -54.69 -52.89 60.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.604 -1.188 . . . . 0.0 109.562 178.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.512 ' H1 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -87.15 153.07 21.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.866 0.365 . . . . 0.0 111.264 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 3' ' ' LEU . 98.2 mt -119.26 121.85 40.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -75.43 142.07 43.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.845 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.407 ' HH ' ' CD ' ' A' ' 15' ' ' GLU . 23.9 p90 -149.71 160.22 43.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.967 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -79.7 108.75 13.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.96 0.41 . . . . 0.0 111.192 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.85 140.88 24.66 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -90.2 115.65 27.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 110.521 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.1 -43.66 2.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.493 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -173.5 155.23 2.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.027 0.413 . . . . 0.0 110.761 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 15.7 m -78.34 164.15 25.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.622 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -78.93 150.57 32.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.638 0.256 . . . . 0.0 110.389 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -64.98 74.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.941 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.39 -29.99 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 16.1 pt-20 -96.44 -173.58 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 16' ' ' ARG . 3.4 ptp85 -131.8 142.87 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.901 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG21 ' N ' ' A' ' 18' ' ' ARG . 7.4 p -78.59 143.0 13.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.422 ' N ' HG21 ' A' ' 17' ' ' VAL . 60.6 ttp85 -150.55 39.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.874 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.5 29.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.593 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.6 p -141.83 144.25 33.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.6 m -119.08 37.48 4.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 111.171 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 -173.39 22.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.115 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 23' ' ' ILE . 20.5 pt -61.2 119.2 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.833 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 70.39 24.29 4.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.685 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 51.7 m-85 -139.5 140.93 37.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.2 pt? -144.8 152.62 40.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.62 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 124.83 28.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -121.79 142.41 50.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.882 0.373 . . . . 0.0 111.065 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.544 ' HB3' HD21 ' A' ' 2' ' ' LEU . 39.8 m -135.35 118.3 12.71 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.699 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo -63.0 163.84 21.22 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.527 2.818 . . . . 0.0 114.229 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -95.05 58.33 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' C ' ' H1 ' ' A' ' 1' ' ' GLY . 8.5 ttp180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.244 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.688 ' HG ' HH22 ' A' ' 16' ' ' ARG . 10.0 mp 65.18 40.24 5.07 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.742 0.417 . . . . 0.0 111.483 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 3.6 mm? -91.56 114.39 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.913 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.735 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 17.9 m -71.51 141.79 50.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -128.59 158.47 38.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.418 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.4 m -82.16 106.6 14.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.071 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.77 137.45 22.39 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -82.11 117.88 22.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.6 2.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.668 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 179.74 146.64 0.22 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.788 0.294 . . . . 0.0 110.578 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 32.0 m -79.87 -176.14 5.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HZ2' ' CD ' ' A' ' 15' ' ' GLU . 1.3 pptp? -151.46 -170.4 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 -64.65 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -163.75 -33.23 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 1.3 pm0 -125.35 153.12 43.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.49 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.688 HH22 ' HG ' ' A' ' 2' ' ' LEU . 0.8 OUTLIER -97.11 122.38 40.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.898 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.502 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 p -69.66 136.22 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.735 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 83.7 mtp180 -126.63 -28.29 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.558 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.68 -159.69 23.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.891 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.7 p -108.54 141.35 40.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.614 0.245 . . . . 0.0 110.9 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.4 t -89.11 -42.84 11.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.179 0.514 . . . . 0.0 109.973 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.6 -156.28 20.5 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.427 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 18.3 pt -62.75 113.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.134 0.493 . . . . 0.0 111.008 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 66.12 26.71 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.383 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 38.4 m-85 -137.22 137.41 39.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.253 0.549 . . . . 0.0 110.957 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 26' ' ' LEU . 8.7 mp -114.84 148.47 38.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.88 113.17 25.18 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 51.0 m -138.3 140.17 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.731 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 32.7 m -95.11 114.68 64.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.307 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 64.5 Cg_endo -72.93 168.6 24.26 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.134 2.556 . . . . 0.0 112.716 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 14' ' ' GLY . 78.9 mtp180 -73.58 52.77 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.224 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.334 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.515 ' H3 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 29' ' ' CYS . 17.5 tp 57.84 45.21 18.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.263 0.554 . . . . 0.0 110.509 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp -75.27 78.4 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.431 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.8 m -55.74 140.61 41.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.14 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -155.11 154.66 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.2 m -78.75 105.59 10.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.087 0.47 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.88 140.82 32.05 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -82.59 116.42 21.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.16 -41.82 2.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.805 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.21 165.21 2.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.776 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 9.6 m -78.33 166.41 22.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 4.6 tppt? -78.45 145.4 35.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -68.39 71.09 0.18 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.64 0.734 . . . . 0.0 110.341 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.06 -29.76 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.047 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 14.1 pt-20 -90.16 178.94 6.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.625 0.25 . . . . 0.0 110.975 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -110.4 134.16 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.022 0.439 . . . . 0.0 111.397 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -75.12 146.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.767 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 mmt85 -119.77 -41.88 2.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.13 -142.24 6.76 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.7 p -127.24 139.99 52.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.008 0.404 . . . . 0.0 111.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -93.3 -38.12 11.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.99 -154.16 18.81 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.0 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -61.77 116.28 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.219 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 44.4 ttp180 64.06 24.55 13.56 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.399 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.07 136.12 36.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 111.068 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.4 mp -128.89 147.81 50.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.388 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.47 122.82 27.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.6 m -132.97 155.37 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.486 0.184 . . . . 0.0 111.123 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 2' ' ' LEU . 60.9 m -139.11 113.62 8.25 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.323 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 18.4 Cg_endo -59.89 139.66 89.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.224 2.616 . . . . 0.0 113.058 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -83.15 56.96 3.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.128 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.515 ' C ' ' H3 ' ' A' ' 1' ' ' GLY . 13.8 tpp85 . . . . . 0 C--O 1.244 0.812 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.008 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.424 ' HB3' ' NH1' ' A' ' 31' ' ' ARG . 86.5 mt -82.55 43.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.156 0.478 . . . . 0.0 111.084 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 3' ' ' LEU . 3.2 mm? -124.38 139.46 53.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -68.91 141.01 55.13 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.401 0.438 . . . . 0.0 111.484 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.56 153.95 32.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.658 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.03 116.16 20.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 112.159 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.61 148.53 23.83 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -90.08 122.01 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.826 0.346 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.88 -43.27 1.92 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.576 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -174.9 157.1 2.34 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.257 0.529 . . . . 0.0 111.013 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.566 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 58.3 m -79.06 163.51 25.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.373 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 35.0 mtmm -86.52 147.52 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.251 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -63.82 82.62 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.434 0.635 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.48 -33.06 0.16 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 5.5 pt-20 -96.67 154.88 17.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.802 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.32 141.86 34.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 HD21 ' A' ' 26' ' ' LEU . 35.4 m -69.75 143.39 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.509 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -48.04 2.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.562 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.77 -174.95 46.46 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 p -89.64 139.51 30.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.562 0.681 . . . . 0.0 111.283 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 96.2 m -97.84 -42.56 7.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.144 0.497 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.26 -156.17 23.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.447 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 pt -62.19 112.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.212 0.53 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 66.13 24.56 10.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.742 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 17.9 m-85 -130.14 136.19 49.02 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 17' ' ' VAL . 20.4 tp -132.58 137.96 47.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 119.16 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.37 139.69 50.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.73 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 82.3 m -124.19 103.59 32.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.782 0.325 . . . . 0.0 110.603 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.42 131.91 15.6 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.831 2.354 . . . . 0.0 111.418 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 2' ' ' LEU . 34.6 ttm-85 -172.52 94.08 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.239 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HD3' ' OXT' ' A' ' 32' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.404 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 30' ' ' PRO . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 2' ' ' LEU . 4.0 mm? -78.26 63.04 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.597 0.237 . . . . 0.0 111.525 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.06 134.09 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 110.522 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.0 m -76.15 141.99 41.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.678 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.25 166.26 33.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.714 0.292 . . . . 0.0 110.596 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 47.7 t -79.56 118.61 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.571 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 138.29 13.9 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.626 ' HB3' ' HZ1' ' A' ' 8' ' ' LYS . 7.8 mtpm? -91.16 118.22 30.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.544 0.211 . . . . 0.0 110.927 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.49 -44.74 2.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.479 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.408 ' HA ' HD23 ' A' ' 26' ' ' LEU . 28.5 p80 -172.39 157.73 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.959 0.38 . . . . 0.0 110.422 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 35.5 m -78.4 164.76 24.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -87.62 152.79 21.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -52.15 116.91 2.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.916 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.38 -26.18 7.86 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.845 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 1.099 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 76.5 mt-10 -85.69 136.37 33.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.622 -0.289 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -100.31 131.37 46.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.668 HG23 HD11 ' A' ' 26' ' ' LEU . 6.5 p -65.86 129.12 29.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 110.505 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.8 tmm_? -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.527 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -156.64 25.4 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.928 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -89.11 150.7 22.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.795 0.331 . . . . 0.0 111.494 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.1 t -119.7 -41.83 2.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.71 -156.74 18.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -65.58 111.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.388 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' C ' ' HD1' ' A' ' 25' ' ' PHE . 62.5 mmt-85 62.0 22.67 13.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.438 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' HD1' ' C ' ' A' ' 24' ' ' ARG . 4.7 m-30 -122.92 142.23 51.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.672 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 17' ' ' VAL . 2.5 pt? -139.1 148.95 43.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HD2' ' HE ' ' A' ' 18' ' ' ARG . 1.9 t80 -79.58 126.42 30.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.6 m -117.82 136.93 53.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.758 0.313 . . . . 0.0 111.23 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.3 92.92 47.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.349 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.099 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 42.5 Cg_endo -75.17 141.38 26.11 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.595 2.197 . . . . 0.0 112.794 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -103.51 39.81 1.53 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.777 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.553 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.4 pp -83.26 32.82 0.45 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.132 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD22 ' HG2' ' A' ' 30' ' ' PRO . 54.6 tp -172.68 128.55 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.744 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.93 144.02 16.06 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -160.54 162.53 32.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 15.2 t -86.02 119.93 26.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.176 0.512 . . . . 0.0 111.592 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.09 135.45 13.22 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.622 ' HZ2' ' HB2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -87.24 118.41 26.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.46 1.87 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -171.36 157.21 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 17' ' ' VAL . 60.1 m -78.49 169.94 17.45 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.489 0.493 . . . . 0.0 110.362 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 28.2 ttmt -78.77 141.34 37.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -61.31 90.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.03 -35.73 0.72 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 5.1 pt-20 -88.3 172.11 9.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.85 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -118.84 144.6 46.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG12 ' SG ' ' A' ' 11' ' ' CYS . 28.5 m -69.02 138.48 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD3' ' CD2' ' A' ' 27' ' ' TYR . 80.5 ttt180 -115.68 -28.28 6.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.413 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.84 -154.08 15.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 16.1 p -132.27 140.68 48.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.745 0.273 . . . . 0.0 110.641 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 4.6 m -93.14 -37.88 11.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.183 0.516 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.07 -152.21 13.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.585 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.21 114.93 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.125 0.488 . . . . 0.0 111.283 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 64.94 22.97 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.607 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 7.9 m-85 -128.67 134.63 48.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.497 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 6.7 mp -133.6 142.72 48.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.982 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 18' ' ' ARG . 2.7 t80 -81.52 129.5 34.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 m -129.33 147.08 51.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.021 0.439 . . . . 0.0 111.63 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 74.9 m -135.02 118.22 13.01 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.58 ' HG2' HD22 ' A' ' 3' ' ' LEU . 18.3 Cg_exo -67.77 -179.14 1.89 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.192 2.594 . . . . 0.0 113.623 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.02 55.13 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HD2' HD23 ' A' ' 3' ' ' LEU . 7.3 ptp85 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.58 137.99 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.839 0.32 . . . . 0.0 110.26 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 3' ' ' LEU . 6.9 mp -82.24 56.38 3.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.654 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 87.3 m -76.3 141.57 41.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.56 157.11 29.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.9 m -80.36 113.64 18.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.085 0.469 . . . . 0.0 110.961 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.03 144.03 25.78 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.504 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -86.12 113.49 22.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 110.966 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.37 -40.28 1.28 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.636 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -170.36 156.67 5.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.001 0.401 . . . . 0.0 110.552 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.557 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 30.9 m -78.48 162.18 26.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.846 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.2 mtmp? -81.54 141.38 33.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.723 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -54.51 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.96 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.79 -41.65 0.69 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 7.9 pt-20 -87.82 -176.31 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 110.973 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -132.63 144.78 50.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 111.304 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 26' ' ' LEU . 25.1 t -73.3 139.5 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 32.1 mmt180 -118.77 -31.51 4.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.11 -143.62 5.84 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.828 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.737 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.3 p -136.62 148.26 47.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.647 0.224 . . . . 0.0 110.409 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -160.27 98.33 1.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 151.45 24.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.709 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.703 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 20.0 pt -59.0 122.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.663 0.231 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 14.2 ptt-85 61.93 24.4 14.52 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.549 1.14 . . . . 0.0 111.734 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.11 140.37 52.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.926 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.737 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.3 pt? -126.39 153.06 45.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.442 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.15 121.8 24.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.19 139.37 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.852 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.8 m -133.11 124.94 18.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.89 147.21 84.8 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.045 2.497 . . . . 0.0 112.709 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -80.97 -41.0 23.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.491 -1.243 . . . . 0.0 108.471 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -161.18 153.87 20.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.09 123.76 3.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.6 m -150.66 143.29 24.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -153.86 160.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.096 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.8 m -88.05 110.64 20.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.996 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.57 134.76 15.11 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.59 118.48 23.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 110.23 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA2' ' HG3' ' A' ' 24' ' ' ARG . . . 79.64 -41.2 2.31 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -175.09 144.68 0.76 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.765 0.282 . . . . 0.0 110.788 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.603 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 58.0 m -84.95 -178.54 6.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -81.69 142.43 32.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -64.15 86.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.289 0.566 . . . . 0.0 111.166 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.83 -19.07 0.57 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.603 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 83.5 mt-10 -78.48 148.31 33.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -85.24 115.54 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.62 HG22 HD22 ' A' ' 26' ' ' LEU . 4.2 p -74.0 138.57 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.9 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.617 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 55.9 mtp85 -115.09 -43.56 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.785 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.88 -171.48 43.38 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.682 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 p -88.91 143.86 26.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.017 0.409 . . . . 0.0 110.899 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.8 p -145.39 44.4 1.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.0 111.735 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.62 168.63 13.75 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 pt -63.91 109.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 110.098 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG3' ' HA2' ' A' ' 9' ' ' GLY . 11.0 tpt180 65.3 26.99 12.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.874 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 5.5 m-85 -113.15 135.12 54.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.182 0.515 . . . . 0.0 110.158 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD22 HG22 ' A' ' 17' ' ' VAL . 20.7 tp -121.16 125.74 47.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.744 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 t80 -79.03 119.58 22.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -137.18 142.3 42.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 111.222 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 76.8 m -103.37 104.7 42.77 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 72.0 Cg_endo -81.93 138.47 10.37 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.574 2.183 . . . . 0.0 114.574 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.739 ' H ' ' HD3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.62 -19.45 32.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.971 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 . . . . . 0 C--O 1.256 1.435 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.304 -179.709 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.496 HD21 ' HB3' ' A' ' 29' ' ' CYS . 24.6 tp -158.57 154.59 26.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -76.38 55.64 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.969 0.414 . . . . 0.0 111.538 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.2 m -78.69 137.38 37.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.84 160.27 27.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -80.52 117.16 21.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.193 0.521 . . . . 0.0 112.157 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.29 139.69 14.89 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.09 129.0 37.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.025 0.44 . . . . 0.0 110.023 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -48.56 3.88 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.449 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.0 p80 179.27 160.4 0.72 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.801 0.3 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 163.18 25.68 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -94.14 153.25 18.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -49.71 108.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.09 -27.05 4.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.429 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 1.05 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 94.8 mt-10 -87.71 135.55 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.835 0.35 . . . . 0.0 110.613 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -91.94 125.76 36.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.25 134.98 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -110.61 -34.83 6.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.131 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.09 -152.48 14.87 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.4 p -118.62 138.8 52.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.047 0.424 . . . . 0.0 111.144 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -93.01 -37.13 12.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 110.279 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.02 14.84 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.63 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.452 HD11 HG21 ' A' ' 23' ' ' ILE . 17.0 pt -61.48 114.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 111.504 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 63.44 21.78 12.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.723 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.94 136.64 51.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.146 0.498 . . . . 0.0 111.086 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.0 mp -128.54 147.2 50.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.353 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.95 122.84 27.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.48 136.46 54.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.976 0.417 . . . . 0.0 111.667 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HB3' HD21 ' A' ' 2' ' ' LEU . 90.9 m -129.43 96.78 26.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.05 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 32.2 Cg_endo -63.6 156.95 53.96 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -60.8 -20.46 61.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.404 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' N ' ' HE ' ' A' ' 31' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.92 138.49 48.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.837 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -77.82 145.95 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.958 0.409 . . . . 0.0 110.908 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.07 150.68 43.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.189 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.87 167.75 28.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.958 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.702 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 72.0 m -79.52 104.6 10.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.41 -178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.78 26.89 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.69 108.37 17.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.8 -40.71 1.4 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.43 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -167.67 163.61 14.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 32.2 m -78.46 161.3 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.463 . . . . 0.0 110.522 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.51 157.94 15.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.265 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -52.52 120.32 5.48 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.04 10.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.524 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 1.067 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 78.5 mt-10 -86.49 130.73 34.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.708 0.289 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.39 121.65 39.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.27 132.26 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -102.6 -43.37 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.113 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.41 -135.38 3.66 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -89.55 139.84 30.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.981 0.391 . . . . 0.0 110.823 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.21 -42.56 5.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.254 0.55 . . . . 0.0 110.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.75 21.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 pt -62.04 110.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.288 0.566 . . . . 0.0 110.912 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 59.87 27.97 17.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.199 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 25.9 m-85 -123.81 138.29 54.53 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -99.66 136.7 39.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.806 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.05 114.31 19.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.1 m -123.22 135.78 54.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 111.739 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 m -128.57 100.61 21.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.197 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.067 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 43.4 Cg_endo -69.56 141.38 45.88 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.539 2.159 . . . . 0.0 113.646 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HA ' ' NE ' ' A' ' 31' ' ' ARG . 2.7 tpm_? -120.75 75.44 1.13 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.685 0.755 . . . . 0.0 109.989 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' A' ' 32' ' ' ARG . 13.8 ttp85 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.749 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 2' ' ' LEU . 1.6 pt? -78.04 51.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 111.376 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.43 57.95 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.302 0.572 . . . . 0.0 109.934 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 56.6 m -67.38 139.84 57.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.017 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.01 174.88 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 95.6 m -83.07 112.54 19.89 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.51 130.87 9.99 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 10' ' ' HIS . 37.2 mtmm -74.4 101.39 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.35 . . . . 0.0 111.633 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.12 -32.62 0.93 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.718 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.415 ' H ' ' C ' ' A' ' 8' ' ' LYS . 19.0 p-80 -167.15 151.56 6.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.928 0.364 . . . . 0.0 110.338 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.518 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 63.5 m -79.57 166.05 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.936 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 12' ' ' LYS . 1.7 ttmp? -79.39 145.53 33.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.612 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -64.98 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.33 0.586 . . . . 0.0 111.341 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.12 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.489 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 28' ' ' CYS . 1.7 pt-20 -99.32 157.35 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 111.271 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -93.63 137.13 33.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.875 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -82.69 118.94 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 46.0 tpt85 -89.94 -35.92 15.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.663 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.25 -137.22 4.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.678 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -90.88 142.35 27.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.52 0.2 . . . . 0.0 110.959 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -113.0 -40.64 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.127 0.489 . . . . 0.0 109.884 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.33 -157.85 17.71 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.5 111.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 58.61 26.77 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.877 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 24.1 m-85 -124.04 137.3 54.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 26' ' ' LEU . 9.2 mp -105.5 145.93 30.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.021 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -79.44 108.72 13.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 12.8 m -110.03 131.61 54.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.382 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -122.77 106.81 34.18 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 35.4 Cg_endo -66.69 143.65 68.79 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.148 2.565 . . . . 0.0 113.597 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 9.1 ttp180 -163.26 -38.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.579 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 51.3 mtp180 . . . . . 0 C--O 1.246 0.869 0 O-C-N 123.902 0.751 . . . . 0.0 110.08 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.92 76.62 4.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.224 0.535 . . . . 0.0 110.102 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.589 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 5.0 tt -123.15 125.24 44.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.43 147.24 28.03 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.0 155.68 29.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.794 0.33 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.77 107.07 16.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.944 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.04 139.27 24.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -89.92 117.13 28.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.45 -43.78 2.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -165.68 146.75 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 61.7 m -86.49 -163.85 0.96 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.602 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -79.85 149.89 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.624 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -67.25 117.78 9.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 1.07 60.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.035 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.646 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 5.5 tt0 -78.7 149.21 32.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.6 mmm-85 -98.23 121.1 39.75 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.549 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.4 138.11 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -111.45 -39.88 4.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.578 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.7 178.61 44.71 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -89.23 138.97 30.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.158 0.479 . . . . 0.0 110.891 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 67.7 m -92.76 -39.09 11.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.071 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.8 -154.92 19.78 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 23' ' ' ILE . 16.6 pt -62.1 113.88 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.199 0.524 . . . . 0.0 111.233 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 64.57 21.47 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.725 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.673 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 3.8 m-85 -121.54 134.87 55.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.029 0.442 . . . . 0.0 111.006 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -131.98 128.25 38.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.661 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 t80 -81.99 120.26 25.03 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 79.0 m -135.27 150.87 50.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 111.403 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.9 m -124.15 115.72 27.4 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.546 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 59.0 Cg_endo -80.54 139.55 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 113.847 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -81.06 -24.18 38.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 . . . . . 0 C--O 1.243 0.719 0 CA-C-N 114.328 -1.306 . . . . 0.0 107.802 179.261 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.0 mt -36.9 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.809 0.946 . . . . 0.0 112.808 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.14 63.81 2.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 62.9 m -56.68 137.05 54.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.634 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.95 164.44 34.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.4 t -79.36 103.4 9.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.798 0.332 . . . . 0.0 111.018 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.11 136.15 19.04 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -91.89 115.88 28.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.73 0.3 . . . . 0.0 111.096 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.76 -43.48 1.65 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.088 -0.577 . . . . 0.0 114.338 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -172.49 148.84 2.06 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.519 0.659 . . . . 0.0 111.317 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.4 m -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.457 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 56.5 tptt -79.17 134.94 36.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.398 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -58.38 97.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.941 0.4 . . . . 0.0 110.239 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.36 0.67 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.729 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 15.9 pt-20 -86.86 167.38 14.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -112.39 133.97 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.667 HG12 HD12 ' A' ' 26' ' ' LEU . 36.3 t -73.11 131.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.102 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HD2' ' HD2' ' A' ' 27' ' ' TYR . 58.9 ttm-85 -93.13 -38.03 11.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.918 0.389 . . . . 0.0 110.174 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.76 -160.64 28.07 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -89.71 142.81 27.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.743 0.306 . . . . 0.0 111.506 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.9 t -104.46 -42.65 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.031 0.443 . . . . 0.0 110.09 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.83 -152.53 11.38 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 pt -63.9 110.57 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 59.89 25.75 14.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.08 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.11 142.57 51.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.745 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.667 HD12 HG12 ' A' ' 17' ' ' VAL . 2.2 pt? -140.52 147.9 40.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.583 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 1.2 t80 -79.9 121.73 25.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 17.3 m -113.14 143.04 45.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.931 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -127.37 103.61 22.55 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.74 0.305 . . . . 0.0 110.242 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.729 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 42.0 Cg_endo -67.54 156.69 65.05 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.186 2.59 . . . . 0.0 112.41 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -78.43 55.73 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.2 mt 60.62 44.75 11.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.937 0.433 . . . . 0.0 111.482 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.84 140.59 36.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.469 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.49 145.5 55.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.281 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.4 165.79 33.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 93.5 m -85.79 106.67 17.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.941 0.4 . . . . 0.0 110.845 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -72.33 151.58 46.98 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.765 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -86.35 92.17 8.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.73 -38.61 1.93 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.213 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -155.29 149.22 25.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.53 ' SG ' HG11 ' A' ' 17' ' ' VAL . 25.1 m -79.2 179.69 7.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -79.49 140.0 37.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -63.48 74.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.383 0.611 . . . . 0.0 111.845 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.75 -35.47 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.184 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 3.6 pt-20 -83.75 -178.33 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.881 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HD2' ' C ' ' A' ' 15' ' ' GLU . 1.4 mpt_? -125.5 140.78 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 111.322 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG11 ' SG ' ' A' ' 11' ' ' CYS . 33.7 m -72.3 149.74 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 28.2 mmm180 -125.68 -33.17 2.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.61 -151.93 10.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.604 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.1 p -129.39 141.41 51.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.838 0.319 . . . . 0.0 110.715 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.3 m -97.29 -38.27 9.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.628 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.21 -154.89 22.45 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.053 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 17.2 pt -61.57 112.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.444 0.64 . . . . 0.0 111.063 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.9 mmt-85 64.5 31.7 12.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.168 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.695 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 41.5 m-85 -140.86 136.78 32.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.153 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.7 pt? -143.91 151.26 39.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.74 123.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.8 m -124.54 139.31 53.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 95.1 m -127.27 115.4 21.58 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 6.0 Cg_exo -78.29 140.02 17.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.318 2.679 . . . . 0.0 111.441 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -116.82 -16.3 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.197 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 32' ' ' ARG . 3.5 ptm180 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' H2 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.777 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.6 pt? -65.75 113.48 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 110.476 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 3' ' ' LEU . 1.4 tm? -167.63 125.59 1.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 81.0 m -77.82 139.16 39.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.629 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -157.28 161.27 39.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.203 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 21.0 t -79.28 105.87 10.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.28 142.14 21.93 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.328 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -91.86 120.34 32.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.03 -52.27 2.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.385 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.32 155.28 0.5 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.202 0.501 . . . . 0.0 111.848 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.544 ' SG ' HD23 ' A' ' 26' ' ' LEU . 3.3 m -79.2 169.96 17.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.686 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.654 ' HG2' ' OE2' ' A' ' 15' ' ' GLU . 28.4 mmtt -81.61 160.85 23.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -66.84 72.19 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.006 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.39 -26.12 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.375 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.947 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.4 mt-10 -79.17 145.88 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.311 . . . . 0.0 110.384 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -83.62 125.62 32.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.69 HG22 HD21 ' A' ' 26' ' ' LEU . 3.7 p -76.47 132.96 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 27' ' ' TYR . 27.0 mmm180 -113.03 -44.69 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.452 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.38 -145.95 10.26 Favored Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.378 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -107.02 143.01 35.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.018 0.409 . . . . 0.0 110.683 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 7.8 p -122.14 11.14 10.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 111.057 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.93 -173.5 36.62 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 pt -65.28 114.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.388 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 63.18 23.67 14.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.964 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 22.7 m-30 -115.14 138.36 50.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.345 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.69 HD21 HG22 ' A' ' 17' ' ' VAL . 5.4 tt -122.51 136.17 54.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 2.7 t80 -78.13 117.76 19.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 57.1 m -109.05 140.72 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.029 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.26 80.33 19.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.947 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 19.7 Cg_endo -57.73 151.47 55.5 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.9 2.4 . . . . 0.0 112.635 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 21.21 17.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.961 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' C ' ' H2 ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.484 1.867 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 2' ' ' LEU . 10.3 mp 70.83 149.57 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.066 0.509 . . . . 0.0 111.025 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 63.15 4.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 48.7 m -66.14 137.45 57.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.591 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.94 160.82 40.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.789 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.41 118.32 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.078 0.466 . . . . 0.0 111.943 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.04 154.8 24.0 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.377 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.61 108.73 19.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 111.474 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.66 -40.32 0.95 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.95 154.03 17.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.068 0.434 . . . . 0.0 110.919 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' SG ' HD11 ' A' ' 26' ' ' LEU . 16.6 m -79.12 161.96 26.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.087 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HD3' ' OE2' ' A' ' 15' ' ' GLU . 1.6 tttt -80.19 152.8 28.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.703 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -52.99 132.24 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.052 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 32' ' ' ARG . . . 100.6 -26.49 24.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.59 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 21.9 mt-10 -82.36 149.59 27.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -108.67 129.52 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 p -66.75 130.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.26 0.553 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 7.8 tpm_? -97.07 -40.91 8.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.87 -160.77 33.4 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.784 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.5 p -89.57 143.11 27.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.946 0.373 . . . . 0.0 111.363 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 52.3 t -110.33 -41.25 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.969 0.414 . . . . 0.0 110.29 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.99 -157.69 23.89 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.8 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -64.16 109.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.5 0.667 . . . . 0.0 110.542 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 62.51 30.5 17.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.059 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.606 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 29.1 m-85 -131.52 139.42 49.27 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.499 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD21 ' N ' ' A' ' 26' ' ' LEU . 2.6 pt? -140.49 143.64 35.59 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.3 t80 -78.3 123.28 26.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 55.9 m -121.5 140.0 52.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.192 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -120.43 96.72 49.03 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 33.9 Cg_endo -66.5 135.09 37.94 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.732 2.288 . . . . 0.0 114.353 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -119.85 -16.74 8.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.495 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 39.1 mmt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.19 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' HA ' HD21 ' A' ' 2' ' ' LEU . 94.7 mt 70.99 136.19 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.306 0.651 . . . . 0.0 111.433 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 3' ' ' LEU . 6.7 mp -81.1 60.94 4.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.747 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.0 m -62.58 138.45 58.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.98 163.26 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 70.0 m -91.75 107.93 19.55 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.873 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 148.24 40.46 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.073 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -83.84 108.72 17.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.632 0.253 . . . . 0.0 110.395 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.17 -43.16 1.72 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.865 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.09 142.06 3.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.582 0.229 . . . . 0.0 110.518 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.5 m -84.08 174.29 10.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.2 142.16 34.96 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -60.32 109.13 0.92 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.36 -26.61 2.28 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 1.029 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 41.4 mt-10 -78.8 139.16 38.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.269 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -82.95 97.9 8.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.92 127.89 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -95.88 -39.68 9.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.485 . . . . 0.0 109.728 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.9 -153.92 23.13 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.546 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -88.87 140.0 29.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.72 0.295 . . . . 0.0 111.042 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.3 t -93.87 -42.69 8.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.287 0.565 . . . . 0.0 110.004 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.21 -152.41 14.6 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.401 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 16.9 pt -58.6 116.05 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.775 0.287 . . . . 0.0 110.323 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 15.4 ptm180 49.9 29.24 3.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 112.137 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 3.5 m-30 -122.45 137.89 54.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 21.7 tp -117.69 132.35 56.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.644 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.64 120.79 34.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 56.5 m -137.03 154.3 50.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.034 0.445 . . . . 0.0 111.724 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 81.4 m -123.52 91.68 49.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.558 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.029 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 29.2 Cg_endo -64.4 138.41 60.21 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.496 2.131 . . . . 0.0 112.661 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -71.1 -67.64 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.755 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 32' ' ' ARG . 5.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.054 0.846 . . . . 0.0 111.528 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' H3 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 29' ' ' CYS . 48.0 tp 74.62 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 110.623 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.92 78.2 0.46 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 32.5 m -60.93 138.91 58.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.063 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.75 157.31 43.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -85.97 115.48 23.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.468 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 11' ' ' CYS . . . -85.19 135.71 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -86.39 114.49 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.029 0.442 . . . . 0.0 110.38 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.52 3.69 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.061 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 179.58 137.58 0.11 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.397 . . . . 0.0 110.301 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 38.4 m -80.2 -154.47 0.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.593 ' HB2' ' OE2' ' A' ' 15' ' ' GLU . 10.1 mmpt? -106.39 152.31 23.76 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -68.36 63.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.799 0.809 . . . . 0.0 110.558 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.78 -35.77 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.371 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.901 ' HG3' ' HB3' ' A' ' 30' ' ' PRO . 2.4 mp0 -79.9 138.3 37.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.061 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.47 128.03 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 127.62 30.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.291 0.567 . . . . 0.0 110.606 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -103.36 -33.98 8.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.059 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.63 -152.78 20.4 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 14.1 p -116.43 139.74 50.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.848 0.324 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.1 m -92.57 -38.49 11.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.01 -153.99 14.16 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.793 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 23' ' ' ILE . 17.1 pt -59.25 113.06 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.57 . . . . 0.0 111.628 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 60.91 27.1 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.244 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.34 136.0 49.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.817 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.3 mp -125.48 142.02 51.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -83.75 121.48 27.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 70.1 m -127.17 135.04 50.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 111.689 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.468 ' HB3' HD13 ' A' ' 2' ' ' LEU . 72.9 m -110.15 104.21 55.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.769 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.901 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 72.8 Cg_endo -76.6 146.45 27.16 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.908 2.405 . . . . 0.0 114.038 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.35 57.69 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.956 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' C ' ' H3 ' ' A' ' 1' ' ' GLY . 3.2 tpm_? . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.521 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.4 mt . . . . . 0 CA--C 1.519 -0.218 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.25 140.61 50.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.75 156.06 30.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.4 m -79.58 115.11 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.295 0.569 . . . . 0.0 111.164 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -79.6 145.83 28.03 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.566 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 25' ' ' PHE . 36.1 mtmm -90.58 115.58 27.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.28 -47.73 2.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.012 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HA ' HD21 ' A' ' 26' ' ' LEU . 26.3 p80 -174.22 153.31 1.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.725 0.262 . . . . 0.0 110.359 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.31 163.29 25.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 1.1 ptmm? -106.56 170.58 7.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -49.52 135.23 18.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.355 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.47 20.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.132 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 57.5 mt-10 -95.18 136.53 35.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.931 0.396 . . . . 0.0 111.367 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -103.36 128.06 50.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.13 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.3 138.2 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.71 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 79.6 mtp180 -135.84 38.69 2.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.96 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.13 -148.16 17.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.885 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 11.9 p -134.75 157.53 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.35 0.26 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 p -154.41 46.22 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.744 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.96 165.36 14.38 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 pt -64.59 112.27 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.119 0.459 . . . . 0.0 109.765 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 67.21 18.35 10.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.499 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 2.8 m-85 -115.18 136.92 52.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.838 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.885 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 pt? -121.36 155.38 34.9 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.251 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.72 121.07 24.27 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.5 m -121.29 128.54 52.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.71 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 75.0 m -124.38 98.03 38.83 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.862 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 74.1 Cg_endo . . . . . 0 N--CA 1.46 -0.448 0 C-N-CA 122.994 2.462 . . . . 0.0 112.911 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.83 144.42 30.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.79 165.61 34.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.56 118.9 24.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.172 0.511 . . . . 0.0 112.12 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.93 143.85 19.95 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.7 110.44 16.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.665 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 24' ' ' ARG . . . 75.88 -41.36 1.47 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.793 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -170.36 159.89 7.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.174 0.487 . . . . 0.0 110.72 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 22.4 m -79.07 162.66 25.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -83.54 153.05 24.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -66.25 74.59 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.491 0.662 . . . . 0.0 111.164 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 -30.05 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.635 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 13.4 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -111.02 141.72 44.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.888 0.375 . . . . 0.0 111.336 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' SG ' ' A' ' 11' ' ' CYS . 29.2 m -64.53 138.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.405 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -113.54 -31.13 6.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.31 -144.56 8.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.8 p -132.49 141.13 48.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.723 0.261 . . . . 0.0 110.406 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 75.0 m -96.53 -38.85 9.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.883 0.373 . . . . 0.0 110.736 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.95 -150.65 11.98 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.912 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.55 113.6 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.244 0.545 . . . . 0.0 111.558 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 9' ' ' GLY . 6.1 tpm_? 62.7 19.78 11.62 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.885 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 7.6 m-85 -122.9 134.54 54.36 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.631 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.8 mp -125.57 144.52 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.298 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.61 127.69 33.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 m -129.44 146.74 51.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.706 0.289 . . . . 0.0 111.367 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 57.6 m -136.84 115.12 10.26 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 14.1 Cg_exo . . . . . 0 C--O 1.234 0.299 0 C-N-CA 123.062 2.508 . . . . 0.0 112.266 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -75.43 142.07 43.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.845 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.71 160.22 43.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.967 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -79.7 108.75 13.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.96 0.41 . . . . 0.0 111.192 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.85 140.88 24.66 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -90.2 115.65 27.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 110.521 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.1 -43.66 2.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.493 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' HD21 ' A' ' 26' ' ' LEU . 21.5 p-80 -173.5 155.23 2.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.027 0.413 . . . . 0.0 110.761 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 15.7 m -78.34 164.15 25.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.625 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -78.93 150.57 32.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.638 0.256 . . . . 0.0 110.389 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -64.98 74.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.941 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.39 -29.99 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.625 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 16.1 pt-20 -96.44 -173.58 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 16' ' ' ARG . 3.4 ptp85 -131.8 142.87 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.901 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.59 143.0 13.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -150.55 39.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.874 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.5 29.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.593 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.825 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.6 p -141.83 144.25 33.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.6 m -119.08 37.48 4.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 111.171 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 -173.39 22.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.115 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 pt -61.2 119.2 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.833 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 70.39 24.29 4.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.685 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.656 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 51.7 m-85 -139.5 140.93 37.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.825 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.2 pt? -144.8 152.62 40.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.62 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 124.83 28.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -121.79 142.41 50.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.882 0.373 . . . . 0.0 111.065 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 39.8 m -135.35 118.3 12.71 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.699 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo . . . . . 0 CA--C 1.533 0.459 0 C-N-CA 123.527 2.818 . . . . 0.0 114.229 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 3.6 mm? . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.752 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 17.9 m -71.51 141.79 50.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -128.59 158.47 38.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.418 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.4 m -82.16 106.6 14.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.071 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.77 137.45 22.39 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -82.11 117.88 22.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.6 2.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.668 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 19.1 p-80 179.74 146.64 0.22 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.788 0.294 . . . . 0.0 110.578 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 32.0 m -79.87 -176.14 5.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -151.46 -170.4 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 -64.65 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.75 -33.23 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 1.3 pm0 -125.35 153.12 43.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.49 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.11 122.38 40.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.898 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.508 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 p -69.66 136.22 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.752 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 83.7 mtp180 -126.63 -28.29 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.558 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.68 -159.69 23.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.891 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.7 p -108.54 141.35 40.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.614 0.245 . . . . 0.0 110.9 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.4 t -89.11 -42.84 11.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.179 0.514 . . . . 0.0 109.973 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.6 -156.28 20.5 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 18.3 pt -62.75 113.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.134 0.493 . . . . 0.0 111.008 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 66.12 26.71 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.383 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 38.4 m-85 -137.22 137.41 39.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.253 0.549 . . . . 0.0 110.957 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' HIS . 8.7 mp -114.84 148.47 38.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.88 113.17 25.18 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 51.0 m -138.3 140.17 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.731 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 32.7 m -95.11 114.68 64.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.307 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 64.5 Cg_endo . . . . . 0 C--O 1.234 0.311 0 C-N-CA 123.134 2.556 . . . . 0.0 112.716 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.686 0.279 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 81.8 m -55.74 140.61 41.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.14 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -155.11 154.66 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 98.2 m -78.75 105.59 10.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.087 0.47 . . . . 0.0 110.607 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.88 140.82 32.05 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -82.59 116.42 21.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.16 -41.82 2.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.805 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.21 165.21 2.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.776 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 17' ' ' VAL . 9.6 m -78.33 166.41 22.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 4.6 tppt? -78.45 145.4 35.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -68.39 71.09 0.18 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.64 0.734 . . . . 0.0 110.341 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.06 -29.76 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.047 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 14.1 pt-20 -90.16 178.94 6.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.625 0.25 . . . . 0.0 110.975 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -110.4 134.16 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.022 0.439 . . . . 0.0 111.397 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 11' ' ' CYS . 34.3 m -75.12 146.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.767 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 mmt85 -119.77 -41.88 2.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.13 -142.24 6.76 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.722 HG22 ' HG ' ' A' ' 26' ' ' LEU . 17.7 p -127.24 139.99 52.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.008 0.404 . . . . 0.0 111.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 72.5 m -93.3 -38.12 11.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.99 -154.16 18.81 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.0 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -61.77 116.28 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.219 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 44.4 ttp180 64.06 24.55 13.56 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.399 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 35.5 m-85 -138.07 136.12 36.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 111.068 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.722 ' HG ' HG22 ' A' ' 20' ' ' THR . 7.4 mp -128.89 147.81 50.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.388 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.47 122.82 27.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.6 m -132.97 155.37 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.486 0.184 . . . . 0.0 111.123 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 60.9 m -139.11 113.62 8.25 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.323 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 18.4 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 123.224 2.616 . . . . 0.0 113.058 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.521 -0.171 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -68.91 141.01 55.13 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.401 0.438 . . . . 0.0 111.484 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.56 153.95 32.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.658 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.03 116.16 20.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 112.159 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.61 148.53 23.83 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -90.08 122.01 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.826 0.346 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.88 -43.27 1.92 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.576 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -174.9 157.1 2.34 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.257 0.529 . . . . 0.0 111.013 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 58.3 m -79.06 163.51 25.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.373 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 35.0 mtmm -86.52 147.52 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.251 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -63.82 82.62 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.434 0.635 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.48 -33.06 0.16 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 5.5 pt-20 -96.67 154.88 17.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.802 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.32 141.86 34.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.75 143.39 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.509 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -48.04 2.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.562 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.77 -174.95 46.46 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' HD12 ' A' ' 26' ' ' LEU . 15.3 p -89.64 139.51 30.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.562 0.681 . . . . 0.0 111.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 96.2 m -97.84 -42.56 7.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.144 0.497 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.26 -156.17 23.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.447 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 pt -62.19 112.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.212 0.53 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 66.13 24.56 10.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.742 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 17.9 m-85 -130.14 136.19 49.02 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 20' ' ' THR . 20.4 tp -132.58 137.96 47.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 119.16 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.37 139.69 50.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.73 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 82.3 m -124.19 103.59 32.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.782 0.325 . . . . 0.0 110.603 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.831 2.354 . . . . 0.0 111.418 179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.954 0.407 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.0 m -76.15 141.99 41.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.678 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.25 166.26 33.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.714 0.292 . . . . 0.0 110.596 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 47.7 t -79.56 118.61 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.571 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 138.29 13.9 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 7.8 mtpm? -91.16 118.22 30.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.544 0.211 . . . . 0.0 110.927 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.49 -44.74 2.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.479 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -172.39 157.73 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.959 0.38 . . . . 0.0 110.422 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 35.5 m -78.4 164.76 24.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -87.62 152.79 21.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -52.15 116.91 2.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.916 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.38 -26.18 7.86 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.845 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 1.119 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 76.5 mt-10 -85.69 136.37 33.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.622 -0.289 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -100.31 131.37 46.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.86 129.12 29.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 110.505 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.8 tmm_? -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.527 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -156.64 25.4 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.928 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -89.11 150.7 22.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.795 0.331 . . . . 0.0 111.494 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.1 t -119.7 -41.83 2.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.71 -156.74 18.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -65.58 111.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.388 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' C ' ' HD1' ' A' ' 25' ' ' PHE . 62.5 mmt-85 62.0 22.67 13.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.438 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HD1' ' C ' ' A' ' 24' ' ' ARG . 4.7 m-30 -122.92 142.23 51.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.672 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.5 pt? -139.1 148.95 43.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HE ' ' A' ' 18' ' ' ARG . 1.9 t80 -79.58 126.42 30.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.6 m -117.82 136.93 53.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.758 0.313 . . . . 0.0 111.23 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.3 92.92 47.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.349 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.119 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 42.5 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 122.595 2.197 . . . . 0.0 112.794 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.433 HD23 ' HG2' ' A' ' 30' ' ' PRO . 54.6 tp . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.93 144.02 16.06 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -160.54 162.53 32.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 15.2 t -86.02 119.93 26.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.176 0.512 . . . . 0.0 111.592 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.09 135.45 13.22 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -87.24 118.41 26.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.46 1.87 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -171.36 157.21 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' HG12 ' A' ' 17' ' ' VAL . 60.1 m -78.49 169.94 17.45 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.489 0.493 . . . . 0.0 110.362 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 28.2 ttmt -78.77 141.34 37.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -61.31 90.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.03 -35.73 0.72 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 5.1 pt-20 -88.3 172.11 9.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.85 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -118.84 144.6 46.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.529 HG12 ' SG ' ' A' ' 11' ' ' CYS . 28.5 m -69.02 138.48 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 80.5 ttt180 -115.68 -28.28 6.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.413 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.84 -154.08 15.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.786 HG22 ' HG ' ' A' ' 26' ' ' LEU . 16.1 p -132.27 140.68 48.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.745 0.273 . . . . 0.0 110.641 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 4.6 m -93.14 -37.88 11.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.183 0.516 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.07 -152.21 13.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.585 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.21 114.93 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.125 0.488 . . . . 0.0 111.283 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 64.94 22.97 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.607 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 7.9 m-85 -128.67 134.63 48.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.497 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 20' ' ' THR . 6.7 mp -133.6 142.72 48.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.982 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' A' ' 18' ' ' ARG . 2.7 t80 -81.52 129.5 34.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 m -129.33 147.08 51.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.021 0.439 . . . . 0.0 111.63 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 74.9 m -135.02 118.22 13.01 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 18.3 Cg_exo . . . . . 0 C--O 1.233 0.259 0 C-N-CA 123.192 2.594 . . . . 0.0 113.623 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 121.064 0.459 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 87.3 m -76.3 141.57 41.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.56 157.11 29.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 58.9 m -80.36 113.64 18.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.085 0.469 . . . . 0.0 110.961 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -80.03 144.03 25.78 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.504 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 15.7 ptpt -86.12 113.49 22.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 110.966 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.37 -40.28 1.28 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.636 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -170.36 156.67 5.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.001 0.401 . . . . 0.0 110.552 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 30.9 m -78.48 162.18 26.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.846 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.2 mtmp? -81.54 141.38 33.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.723 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -54.51 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.96 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.79 -41.65 0.69 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 7.9 pt-20 -87.82 -176.31 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 110.973 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -132.63 144.78 50.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 111.304 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.485 HG13 HD12 ' A' ' 26' ' ' LEU . 25.1 t -73.3 139.5 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 32.1 mmt180 -118.77 -31.51 4.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.11 -143.62 5.84 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.828 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.3 p -136.62 148.26 47.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.647 0.224 . . . . 0.0 110.409 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -160.27 98.33 1.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 151.45 24.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.709 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 20.0 pt -59.0 122.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.663 0.231 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 14.2 ptt-85 61.93 24.4 14.52 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.549 1.14 . . . . 0.0 111.734 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.11 140.37 52.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.926 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.3 pt? -126.39 153.06 45.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.442 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.15 121.8 24.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.19 139.37 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.852 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.8 m -133.11 124.94 18.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--O 1.233 0.252 0 C-N-CA 123.045 2.497 . . . . 0.0 112.709 -179.522 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.463 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.6 m -150.66 143.29 24.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -153.86 160.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.096 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.8 m -88.05 110.64 20.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.996 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.57 134.76 15.11 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.59 118.48 23.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 110.23 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 24' ' ' ARG . . . 79.64 -41.2 2.31 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -175.09 144.68 0.76 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.765 0.282 . . . . 0.0 110.788 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 58.0 m -84.95 -178.54 6.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -81.69 142.43 32.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -64.15 86.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.289 0.566 . . . . 0.0 111.166 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.83 -19.07 0.57 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 83.5 mt-10 -78.48 148.31 33.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -85.24 115.54 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.0 138.57 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.9 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.633 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 55.9 mtp85 -115.09 -43.56 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.785 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.88 -171.48 43.38 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.682 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 p -88.91 143.86 26.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.017 0.409 . . . . 0.0 110.899 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.8 p -145.39 44.4 1.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.0 111.735 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.62 168.63 13.75 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 pt -63.91 109.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 110.098 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 11.0 tpt180 65.3 26.99 12.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.874 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 5.5 m-85 -113.15 135.12 54.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.182 0.515 . . . . 0.0 110.158 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -121.16 125.74 47.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.744 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 t80 -79.03 119.58 22.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -137.18 142.3 42.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 111.222 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 76.8 m -103.37 104.7 42.77 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 72.0 Cg_endo . . . . . 0 N--CA 1.453 -0.911 0 C-N-CA 122.574 2.183 . . . . 0.0 114.574 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.969 0.414 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.2 m -78.69 137.38 37.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.84 160.27 27.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -80.52 117.16 21.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.193 0.521 . . . . 0.0 112.157 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.29 139.69 14.89 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.09 129.0 37.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.025 0.44 . . . . 0.0 110.023 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -48.56 3.88 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.449 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.0 p80 179.27 160.4 0.72 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.801 0.3 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 163.18 25.68 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -94.14 153.25 18.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -49.71 108.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.09 -27.05 4.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.429 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.998 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 94.8 mt-10 -87.71 135.55 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.835 0.35 . . . . 0.0 110.613 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -91.94 125.76 36.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.25 134.98 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -110.61 -34.83 6.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.131 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.09 -152.48 14.87 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.4 p -118.62 138.8 52.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.047 0.424 . . . . 0.0 111.144 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -93.01 -37.13 12.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 110.279 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.02 14.84 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.63 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.48 114.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 111.504 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 63.44 21.78 12.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.723 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.94 136.64 51.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.146 0.498 . . . . 0.0 111.086 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.0 mp -128.54 147.2 50.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.353 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.95 122.84 27.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.48 136.46 54.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.976 0.417 . . . . 0.0 111.667 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 90.9 m -129.43 96.78 26.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 32.2 Cg_endo . . . . . 0 N--CA 1.464 -0.228 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.958 0.409 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.07 150.68 43.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.189 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.87 167.75 28.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.958 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 72.0 m -79.52 104.6 10.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.41 -178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.78 26.89 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.69 108.37 17.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.8 -40.71 1.4 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.43 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -167.67 163.61 14.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 32.2 m -78.46 161.3 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.463 . . . . 0.0 110.522 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.51 157.94 15.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.265 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -52.52 120.32 5.48 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.04 10.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.524 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 1.012 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 78.5 mt-10 -86.49 130.73 34.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.708 0.289 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.39 121.65 39.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.27 132.26 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -102.6 -43.37 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.113 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.41 -135.38 3.66 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -89.55 139.84 30.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.981 0.391 . . . . 0.0 110.823 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.21 -42.56 5.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.254 0.55 . . . . 0.0 110.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.75 21.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 pt -62.04 110.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.288 0.566 . . . . 0.0 110.912 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 59.87 27.97 17.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.199 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 25.9 m-85 -123.81 138.29 54.53 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -99.66 136.7 39.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.806 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.05 114.31 19.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.1 m -123.22 135.78 54.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 111.739 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 m -128.57 100.61 21.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.197 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.012 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 43.4 Cg_endo . . . . . 0 N--CA 1.463 -0.277 0 C-N-CA 122.539 2.159 . . . . 0.0 113.646 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.302 0.572 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 56.6 m -67.38 139.84 57.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.017 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.01 174.88 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 95.6 m -83.07 112.54 19.89 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.51 130.87 9.99 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -74.4 101.39 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.35 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.12 -32.62 0.93 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.718 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -167.15 151.56 6.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.928 0.364 . . . . 0.0 110.338 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 63.5 m -79.57 166.05 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.936 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -79.39 145.53 33.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.612 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -64.98 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.33 0.586 . . . . 0.0 111.341 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.12 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.489 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 1.7 pt-20 -99.32 157.35 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 111.271 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -93.63 137.13 33.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.875 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG22 ' SG ' ' A' ' 11' ' ' CYS . 37.4 t -82.69 118.94 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 46.0 tpt85 -89.94 -35.92 15.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.663 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.25 -137.22 4.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.678 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -90.88 142.35 27.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.52 0.2 . . . . 0.0 110.959 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -113.0 -40.64 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.127 0.489 . . . . 0.0 109.884 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.33 -157.85 17.71 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.5 111.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 58.61 26.77 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.877 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 24.1 m-85 -124.04 137.3 54.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.5 145.93 30.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.021 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -79.44 108.72 13.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 12.8 m -110.03 131.61 54.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.382 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -122.77 106.81 34.18 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 35.4 Cg_endo . . . . . 0 C--O 1.234 0.283 0 C-N-CA 123.148 2.565 . . . . 0.0 113.597 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.606 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 5.0 tt . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.43 147.24 28.03 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.0 155.68 29.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.794 0.33 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.77 107.07 16.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.944 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.04 139.27 24.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -89.92 117.13 28.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.45 -43.78 2.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -165.68 146.75 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 61.7 m -86.49 -163.85 0.96 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.602 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -79.85 149.89 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.624 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -67.25 117.78 9.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 1.07 60.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.035 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 5.5 tt0 -78.7 149.21 32.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.6 mmm-85 -98.23 121.1 39.75 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.549 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.4 138.11 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -111.45 -39.88 4.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.578 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.7 178.61 44.71 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -89.23 138.97 30.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.158 0.479 . . . . 0.0 110.891 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 67.7 m -92.76 -39.09 11.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.071 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.8 -154.92 19.78 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.1 113.88 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.199 0.524 . . . . 0.0 111.233 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 64.57 21.47 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.725 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 3.8 m-85 -121.54 134.87 55.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.029 0.442 . . . . 0.0 111.006 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -131.98 128.25 38.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.661 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 t80 -81.99 120.26 25.03 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 79.0 m -135.27 150.87 50.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 111.403 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.9 m -124.15 115.72 27.4 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.546 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 59.0 Cg_endo . . . . . 0 N--CA 1.457 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 113.847 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.819 0.343 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 62.9 m -56.68 137.05 54.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.634 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.95 164.44 34.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.4 t -79.36 103.4 9.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.798 0.332 . . . . 0.0 111.018 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.11 136.15 19.04 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -91.89 115.88 28.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.73 0.3 . . . . 0.0 111.096 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' A' ' 24' ' ' ARG . . . 75.76 -43.48 1.65 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.088 -0.577 . . . . 0.0 114.338 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -172.49 148.84 2.06 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.519 0.659 . . . . 0.0 111.317 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 17' ' ' VAL . 35.4 m -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.457 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 56.5 tptt -79.17 134.94 36.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.398 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -58.38 97.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.941 0.4 . . . . 0.0 110.239 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.36 0.67 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 15.9 pt-20 -86.86 167.38 14.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -112.39 133.97 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' SG ' ' A' ' 11' ' ' CYS . 36.3 t -73.11 131.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.102 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' A' ' 27' ' ' TYR . 58.9 ttm-85 -93.13 -38.03 11.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.918 0.389 . . . . 0.0 110.174 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.76 -160.64 28.07 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -89.71 142.81 27.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.743 0.306 . . . . 0.0 111.506 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.9 t -104.46 -42.65 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.031 0.443 . . . . 0.0 110.09 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.83 -152.53 11.38 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 pt -63.9 110.57 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 54.4 ttm-85 59.89 25.75 14.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.08 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.11 142.57 51.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.745 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.2 pt? -140.52 147.9 40.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 1.2 t80 -79.9 121.73 25.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 17.3 m -113.14 143.04 45.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.931 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -127.37 103.61 22.55 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.74 0.305 . . . . 0.0 110.242 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.698 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 42.0 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 123.186 2.59 . . . . 0.0 112.41 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.646 0.26 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.49 145.5 55.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.281 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.4 165.79 33.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 93.5 m -85.79 106.67 17.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.941 0.4 . . . . 0.0 110.845 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -72.33 151.58 46.98 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.765 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -86.35 92.17 8.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.73 -38.61 1.93 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.213 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -155.29 149.22 25.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.57 ' SG ' HG12 ' A' ' 17' ' ' VAL . 25.1 m -79.2 179.69 7.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -79.49 140.0 37.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -63.48 74.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.383 0.611 . . . . 0.0 111.845 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.75 -35.47 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.184 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 3.6 pt-20 -83.75 -178.33 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.881 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 15' ' ' GLU . 1.4 mpt_? -125.5 140.78 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 111.322 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG12 ' SG ' ' A' ' 11' ' ' CYS . 33.7 m -72.3 149.74 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 28.2 mmm180 -125.68 -33.17 2.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.61 -151.93 10.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.604 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.1 p -129.39 141.41 51.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.838 0.319 . . . . 0.0 110.715 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.725 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.3 m -97.29 -38.27 9.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.628 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.21 -154.89 22.45 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.053 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.49 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 17.2 pt -61.57 112.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.444 0.64 . . . . 0.0 111.063 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.9 mmt-85 64.5 31.7 12.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.168 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 41.5 m-85 -140.86 136.78 32.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.153 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.7 pt? -143.91 151.26 39.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.74 123.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.8 m -124.54 139.31 53.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 95.1 m -127.27 115.4 21.58 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 6.0 Cg_exo . . . . . 0 N--CA 1.459 -0.53 0 C-N-CA 123.318 2.679 . . . . 0.0 111.441 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 tm? . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 81.0 m -77.82 139.16 39.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.629 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -157.28 161.27 39.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.203 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 21.0 t -79.28 105.87 10.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.28 142.14 21.93 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.328 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -91.86 120.34 32.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.03 -52.27 2.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.385 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.32 155.28 0.5 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.202 0.501 . . . . 0.0 111.848 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.571 ' SG ' HD22 ' A' ' 26' ' ' LEU . 3.3 m -79.2 169.96 17.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.686 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.656 ' HG2' ' OE2' ' A' ' 15' ' ' GLU . 28.4 mmtt -81.61 160.85 23.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -66.84 72.19 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.006 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.39 -26.12 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.375 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.954 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.4 mt-10 -79.17 145.88 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.311 . . . . 0.0 110.384 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -83.62 125.62 32.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.011 HG23 HD21 ' A' ' 26' ' ' LEU . 3.7 p -76.47 132.96 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 27' ' ' TYR . 27.0 mmm180 -113.03 -44.69 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.452 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.38 -145.95 10.26 Favored Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.378 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -107.02 143.01 35.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.018 0.409 . . . . 0.0 110.683 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 7.8 p -122.14 11.14 10.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 111.057 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.93 -173.5 36.62 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 pt -65.28 114.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.388 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 63.18 23.67 14.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.964 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 22.7 m-30 -115.14 138.36 50.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.345 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.011 HD21 HG23 ' A' ' 17' ' ' VAL . 5.4 tt -122.51 136.17 54.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 2.7 t80 -78.13 117.76 19.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 57.1 m -109.05 140.72 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.029 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.26 80.33 19.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.954 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 19.7 Cg_endo . . . . . 0 C--O 1.233 0.235 0 C-N-CA 122.9 2.4 . . . . 0.0 112.635 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 48.7 m -66.14 137.45 57.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.591 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.94 160.82 40.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.789 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.41 118.32 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.078 0.466 . . . . 0.0 111.943 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -90.04 154.8 24.0 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.377 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.61 108.73 19.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 111.474 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.66 -40.32 0.95 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.95 154.03 17.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.068 0.434 . . . . 0.0 110.919 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.6 m -79.12 161.96 26.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.087 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD3' ' OE2' ' A' ' 15' ' ' GLU . 1.6 tttt -80.19 152.8 28.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.702 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -52.99 132.24 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.052 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.49 24.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.59 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 21.9 mt-10 -82.36 149.59 27.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -108.67 129.52 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 p -66.75 130.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.26 0.553 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 7.8 tpm_? -97.07 -40.91 8.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.87 -160.77 33.4 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.784 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.5 p -89.57 143.11 27.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.946 0.373 . . . . 0.0 111.363 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 52.3 t -110.33 -41.25 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.969 0.414 . . . . 0.0 110.29 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.99 -157.69 23.89 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.8 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.816 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -64.16 109.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.5 0.667 . . . . 0.0 110.542 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 62.51 30.5 17.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.059 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 29.1 m-85 -131.52 139.42 49.27 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.499 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 7' ' ' GLY . 2.6 pt? -140.49 143.64 35.59 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.3 t80 -78.3 123.28 26.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 55.9 m -121.5 140.0 52.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.192 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -120.43 96.72 49.03 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 33.9 Cg_endo . . . . . 0 C--O 1.233 0.25 0 C-N-CA 122.732 2.288 . . . . 0.0 114.353 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.781 0.325 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.0 m -62.58 138.45 58.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.98 163.26 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 70.0 m -91.75 107.93 19.55 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.873 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 148.24 40.46 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.073 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -83.84 108.72 17.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.632 0.253 . . . . 0.0 110.395 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.17 -43.16 1.72 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.865 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.09 142.06 3.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.582 0.229 . . . . 0.0 110.518 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.5 m -84.08 174.29 10.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.2 142.16 34.96 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -60.32 109.13 0.92 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.36 -26.61 2.28 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 1.017 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 41.4 mt-10 -78.8 139.16 38.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.269 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -82.95 97.9 8.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' SG ' ' A' ' 28' ' ' CYS . 39.4 t -60.92 127.89 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -95.88 -39.68 9.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.485 . . . . 0.0 109.728 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.9 -153.92 23.13 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.546 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -88.87 140.0 29.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.72 0.295 . . . . 0.0 111.042 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.3 t -93.87 -42.69 8.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.287 0.565 . . . . 0.0 110.004 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.21 -152.41 14.6 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 16.9 pt -58.6 116.05 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.775 0.287 . . . . 0.0 110.323 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 15.4 ptm180 49.9 29.24 3.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 112.137 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 3.5 m-30 -122.45 137.89 54.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 21.7 tp -117.69 132.35 56.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.644 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.64 120.79 34.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 17' ' ' VAL . 56.5 m -137.03 154.3 50.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.034 0.445 . . . . 0.0 111.724 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 81.4 m -123.52 91.68 49.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.558 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 29.2 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 C-N-CA 122.496 2.131 . . . . 0.0 112.661 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 32.5 m -60.93 138.91 58.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.063 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.75 157.31 43.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -85.97 115.48 23.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.468 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 11' ' ' CYS . . . -85.19 135.71 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -86.39 114.49 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.029 0.442 . . . . 0.0 110.38 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.52 3.69 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.061 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 179.58 137.58 0.11 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.397 . . . . 0.0 110.301 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 38.4 m -80.2 -154.47 0.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 10.1 mmpt? -106.39 152.31 23.76 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -68.36 63.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.799 0.809 . . . . 0.0 110.558 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.78 -35.77 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.371 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.887 ' HG3' ' HB3' ' A' ' 30' ' ' PRO . 2.4 mp0 -79.9 138.3 37.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.061 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.47 128.03 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 127.62 30.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.291 0.567 . . . . 0.0 110.606 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -103.36 -33.98 8.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.059 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.63 -152.78 20.4 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 14.1 p -116.43 139.74 50.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.848 0.324 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.1 m -92.57 -38.49 11.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.01 -153.99 14.16 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.793 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.25 113.06 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.57 . . . . 0.0 111.628 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 60.91 27.1 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.244 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.34 136.0 49.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.817 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.3 mp -125.48 142.02 51.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -83.75 121.48 27.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 70.1 m -127.17 135.04 50.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 111.689 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 72.9 m -110.15 104.21 55.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.769 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.887 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 72.8 Cg_endo . . . . . 0 C--O 1.232 0.217 0 C-N-CA 122.908 2.405 . . . . 0.0 114.038 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 tp -137.36 47.19 2.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.518 0.675 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.4 mt -139.7 131.17 26.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.675 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.25 140.61 50.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.75 156.06 30.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.4 m -79.58 115.11 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.295 0.569 . . . . 0.0 111.164 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -79.6 145.83 28.03 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.566 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 25' ' ' PHE . 36.1 mtmm -90.58 115.58 27.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.28 -47.73 2.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.012 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HA ' HD21 ' A' ' 26' ' ' LEU . 26.3 p80 -174.22 153.31 1.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.725 0.262 . . . . 0.0 110.359 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.31 163.29 25.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 1.1 ptmm? -106.56 170.58 7.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -49.52 135.23 18.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.355 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.47 20.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.132 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 57.5 mt-10 -95.18 136.53 35.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.931 0.396 . . . . 0.0 111.367 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -103.36 128.06 50.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.13 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.3 138.2 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.71 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 79.6 mtp180 -135.84 38.69 2.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.96 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.13 -148.16 17.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.885 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 11.9 p -134.75 157.53 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.35 0.26 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 p -154.41 46.22 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.744 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.96 165.36 14.38 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 pt -64.59 112.27 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.119 0.459 . . . . 0.0 109.765 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 67.21 18.35 10.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.499 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 2.8 m-85 -115.18 136.92 52.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.838 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.885 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 pt? -121.36 155.38 34.9 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.251 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.72 121.07 24.27 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.5 m -121.29 128.54 52.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.71 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 75.0 m -124.38 98.03 38.83 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.862 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 74.1 Cg_endo -76.59 149.09 30.04 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.994 2.462 . . . . 0.0 112.911 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ptm85 -121.88 32.46 5.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.551 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.251 1.145 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.224 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.28 62.67 3.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.06 0.457 . . . . 0.0 110.575 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp -150.97 135.91 17.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.246 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.83 144.42 30.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.79 165.61 34.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.56 118.9 24.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.172 0.511 . . . . 0.0 112.12 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.93 143.85 19.95 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.7 110.44 16.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.665 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 24' ' ' ARG . . . 75.88 -41.36 1.47 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.793 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -170.36 159.89 7.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.174 0.487 . . . . 0.0 110.72 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 22.4 m -79.07 162.66 25.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -83.54 153.05 24.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -66.25 74.59 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.491 0.662 . . . . 0.0 111.164 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 -30.05 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.635 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 13.4 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -111.02 141.72 44.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.888 0.375 . . . . 0.0 111.336 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' SG ' ' A' ' 11' ' ' CYS . 29.2 m -64.53 138.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.405 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -113.54 -31.13 6.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.31 -144.56 8.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.8 p -132.49 141.13 48.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.723 0.261 . . . . 0.0 110.406 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 75.0 m -96.53 -38.85 9.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.883 0.373 . . . . 0.0 110.736 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.95 -150.65 11.98 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.912 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.55 113.6 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.244 0.545 . . . . 0.0 111.558 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 9' ' ' GLY . 6.1 tpm_? 62.7 19.78 11.62 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.885 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 7.6 m-85 -122.9 134.54 54.36 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.631 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.8 mp -125.57 144.52 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.298 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.61 127.69 33.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 m -129.44 146.74 51.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.706 0.289 . . . . 0.0 111.367 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 57.6 m -136.84 115.12 10.26 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 14.1 Cg_exo -69.34 144.51 56.51 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.062 2.508 . . . . 0.0 112.266 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -54.69 -52.89 60.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.604 -1.188 . . . . 0.0 109.562 178.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.574 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -87.15 153.07 21.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.866 0.365 . . . . 0.0 111.264 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.2 mt -119.26 121.85 40.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -75.43 142.07 43.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.845 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.71 160.22 43.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.967 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -79.7 108.75 13.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.96 0.41 . . . . 0.0 111.192 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.85 140.88 24.66 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -90.2 115.65 27.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 110.521 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.1 -43.66 2.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.493 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' HD21 ' A' ' 26' ' ' LEU . 21.5 p-80 -173.5 155.23 2.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.027 0.413 . . . . 0.0 110.761 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 15.7 m -78.34 164.15 25.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.625 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -78.93 150.57 32.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.638 0.256 . . . . 0.0 110.389 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -64.98 74.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.941 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.39 -29.99 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.625 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 16.1 pt-20 -96.44 -173.58 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 16' ' ' ARG . 3.4 ptp85 -131.8 142.87 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.901 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.59 143.0 13.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -150.55 39.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.874 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.5 29.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.593 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.825 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.6 p -141.83 144.25 33.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.6 m -119.08 37.48 4.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 111.171 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 -173.39 22.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.115 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 pt -61.2 119.2 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.833 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 70.39 24.29 4.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.685 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.656 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 51.7 m-85 -139.5 140.93 37.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.825 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.2 pt? -144.8 152.62 40.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.62 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 124.83 28.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -121.79 142.41 50.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.882 0.373 . . . . 0.0 111.065 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.415 ' HB3' HD23 ' A' ' 2' ' ' LEU . 39.8 m -135.35 118.3 12.71 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.699 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.495 ' O ' ' HG ' ' A' ' 2' ' ' LEU . 28.3 Cg_exo -63.0 163.84 21.22 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.527 2.818 . . . . 0.0 114.229 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -95.05 58.33 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.244 -179.508 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.706 ' HG ' HH22 ' A' ' 16' ' ' ARG . 10.0 mp 65.18 40.24 5.07 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.742 0.417 . . . . 0.0 111.483 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 3.6 mm? -91.56 114.39 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.913 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.752 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 17.9 m -71.51 141.79 50.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -128.59 158.47 38.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.418 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.4 m -82.16 106.6 14.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.071 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.77 137.45 22.39 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -82.11 117.88 22.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.6 2.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.668 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 19.1 p-80 179.74 146.64 0.22 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.788 0.294 . . . . 0.0 110.578 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 32.0 m -79.87 -176.14 5.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -151.46 -170.4 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 -64.65 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -163.75 -33.23 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 1.3 pm0 -125.35 153.12 43.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.49 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.706 HH22 ' HG ' ' A' ' 2' ' ' LEU . 0.8 OUTLIER -97.11 122.38 40.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.898 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.508 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 p -69.66 136.22 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.752 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 83.7 mtp180 -126.63 -28.29 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.558 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.68 -159.69 23.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.891 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.7 p -108.54 141.35 40.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.614 0.245 . . . . 0.0 110.9 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.4 t -89.11 -42.84 11.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.179 0.514 . . . . 0.0 109.973 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.6 -156.28 20.5 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 18.3 pt -62.75 113.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.134 0.493 . . . . 0.0 111.008 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 66.12 26.71 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.383 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 38.4 m-85 -137.22 137.41 39.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.253 0.549 . . . . 0.0 110.957 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' HIS . 8.7 mp -114.84 148.47 38.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.88 113.17 25.18 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 51.0 m -138.3 140.17 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.731 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 32.7 m -95.11 114.68 64.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.307 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 64.5 Cg_endo -72.93 168.6 24.26 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.134 2.556 . . . . 0.0 112.716 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 14' ' ' GLY . 78.9 mtp180 -73.58 52.77 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.224 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.334 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 tp 57.84 45.21 18.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.263 0.554 . . . . 0.0 110.509 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp -75.27 78.4 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.431 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 81.8 m -55.74 140.61 41.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.14 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -155.11 154.66 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 98.2 m -78.75 105.59 10.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.087 0.47 . . . . 0.0 110.607 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.88 140.82 32.05 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -82.59 116.42 21.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.16 -41.82 2.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.805 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.21 165.21 2.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.776 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 17' ' ' VAL . 9.6 m -78.33 166.41 22.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 4.6 tppt? -78.45 145.4 35.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -68.39 71.09 0.18 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.64 0.734 . . . . 0.0 110.341 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.06 -29.76 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.047 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 14.1 pt-20 -90.16 178.94 6.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.625 0.25 . . . . 0.0 110.975 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -110.4 134.16 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.022 0.439 . . . . 0.0 111.397 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 11' ' ' CYS . 34.3 m -75.12 146.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.767 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 mmt85 -119.77 -41.88 2.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.13 -142.24 6.76 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.722 HG22 ' HG ' ' A' ' 26' ' ' LEU . 17.7 p -127.24 139.99 52.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.008 0.404 . . . . 0.0 111.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 72.5 m -93.3 -38.12 11.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.99 -154.16 18.81 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.0 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -61.77 116.28 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.219 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 44.4 ttp180 64.06 24.55 13.56 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.399 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 35.5 m-85 -138.07 136.12 36.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 111.068 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.722 ' HG ' HG22 ' A' ' 20' ' ' THR . 7.4 mp -128.89 147.81 50.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.388 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.47 122.82 27.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.6 m -132.97 155.37 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.486 0.184 . . . . 0.0 111.123 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 60.9 m -139.11 113.62 8.25 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.323 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 18.4 Cg_endo -59.89 139.66 89.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.224 2.616 . . . . 0.0 113.058 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -83.15 56.96 3.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.128 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 . . . . . 0 C--O 1.244 0.812 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.723 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.008 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 31' ' ' ARG . 86.5 mt -82.55 43.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.156 0.478 . . . . 0.0 111.084 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.38 139.46 53.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -68.91 141.01 55.13 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.401 0.438 . . . . 0.0 111.484 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.56 153.95 32.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.658 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.03 116.16 20.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 112.159 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.61 148.53 23.83 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -90.08 122.01 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.826 0.346 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.88 -43.27 1.92 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.576 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -174.9 157.1 2.34 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.257 0.529 . . . . 0.0 111.013 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 58.3 m -79.06 163.51 25.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.373 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 35.0 mtmm -86.52 147.52 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.251 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -63.82 82.62 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.434 0.635 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.48 -33.06 0.16 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 5.5 pt-20 -96.67 154.88 17.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.802 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.32 141.86 34.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.75 143.39 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.509 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -48.04 2.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.562 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.77 -174.95 46.46 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' HD12 ' A' ' 26' ' ' LEU . 15.3 p -89.64 139.51 30.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.562 0.681 . . . . 0.0 111.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 96.2 m -97.84 -42.56 7.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.144 0.497 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.26 -156.17 23.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.447 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 pt -62.19 112.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.212 0.53 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 66.13 24.56 10.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.742 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 17.9 m-85 -130.14 136.19 49.02 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 20' ' ' THR . 20.4 tp -132.58 137.96 47.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 119.16 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.37 139.69 50.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.73 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 82.3 m -124.19 103.59 32.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.782 0.325 . . . . 0.0 110.603 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.42 131.91 15.6 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.831 2.354 . . . . 0.0 111.418 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.484 ' HA ' HD22 ' A' ' 2' ' ' LEU . 34.6 ttm-85 -172.52 94.08 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.239 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' OXT' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.404 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 30' ' ' PRO . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.26 63.04 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.597 0.237 . . . . 0.0 111.525 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.06 134.09 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 110.522 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.0 m -76.15 141.99 41.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.678 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.25 166.26 33.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.714 0.292 . . . . 0.0 110.596 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 47.7 t -79.56 118.61 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.571 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 138.29 13.9 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 7.8 mtpm? -91.16 118.22 30.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.544 0.211 . . . . 0.0 110.927 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.49 -44.74 2.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.479 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -172.39 157.73 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.959 0.38 . . . . 0.0 110.422 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 35.5 m -78.4 164.76 24.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -87.62 152.79 21.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -52.15 116.91 2.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.916 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.38 -26.18 7.86 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.845 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 1.119 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 76.5 mt-10 -85.69 136.37 33.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.622 -0.289 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -100.31 131.37 46.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.86 129.12 29.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 110.505 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.8 tmm_? -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.527 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -156.64 25.4 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.928 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -89.11 150.7 22.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.795 0.331 . . . . 0.0 111.494 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.1 t -119.7 -41.83 2.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.71 -156.74 18.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -65.58 111.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.388 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' C ' ' HD1' ' A' ' 25' ' ' PHE . 62.5 mmt-85 62.0 22.67 13.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.438 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HD1' ' C ' ' A' ' 24' ' ' ARG . 4.7 m-30 -122.92 142.23 51.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.672 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.5 pt? -139.1 148.95 43.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HE ' ' A' ' 18' ' ' ARG . 1.9 t80 -79.58 126.42 30.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.6 m -117.82 136.93 53.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.758 0.313 . . . . 0.0 111.23 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.3 92.92 47.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.349 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.119 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 42.5 Cg_endo -75.17 141.38 26.11 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.595 2.197 . . . . 0.0 112.794 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -103.51 39.81 1.53 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.777 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.553 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 1.4 pp -83.26 32.82 0.45 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.132 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.433 HD23 ' HG2' ' A' ' 30' ' ' PRO . 54.6 tp -172.68 128.55 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.744 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.93 144.02 16.06 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -160.54 162.53 32.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 15.2 t -86.02 119.93 26.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.176 0.512 . . . . 0.0 111.592 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.09 135.45 13.22 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -87.24 118.41 26.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.46 1.87 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -171.36 157.21 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' HG12 ' A' ' 17' ' ' VAL . 60.1 m -78.49 169.94 17.45 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.489 0.493 . . . . 0.0 110.362 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 28.2 ttmt -78.77 141.34 37.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -61.31 90.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.03 -35.73 0.72 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 5.1 pt-20 -88.3 172.11 9.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.85 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -118.84 144.6 46.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG12 ' SG ' ' A' ' 11' ' ' CYS . 28.5 m -69.02 138.48 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 80.5 ttt180 -115.68 -28.28 6.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.413 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.84 -154.08 15.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.786 HG22 ' HG ' ' A' ' 26' ' ' LEU . 16.1 p -132.27 140.68 48.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.745 0.273 . . . . 0.0 110.641 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 4.6 m -93.14 -37.88 11.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.183 0.516 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.07 -152.21 13.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.585 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.21 114.93 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.125 0.488 . . . . 0.0 111.283 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 64.94 22.97 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.607 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 7.9 m-85 -128.67 134.63 48.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.497 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 20' ' ' THR . 6.7 mp -133.6 142.72 48.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.982 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' A' ' 18' ' ' ARG . 2.7 t80 -81.52 129.5 34.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 m -129.33 147.08 51.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.021 0.439 . . . . 0.0 111.63 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 74.9 m -135.02 118.22 13.01 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 18.3 Cg_exo -67.77 -179.14 1.89 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.192 2.594 . . . . 0.0 113.623 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.02 55.13 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.485 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.58 137.99 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.839 0.32 . . . . 0.0 110.26 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.24 56.38 3.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 87.3 m -76.3 141.57 41.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.56 157.11 29.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 58.9 m -80.36 113.64 18.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.085 0.469 . . . . 0.0 110.961 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -80.03 144.03 25.78 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.504 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 15.7 ptpt -86.12 113.49 22.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 110.966 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.37 -40.28 1.28 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.636 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -170.36 156.67 5.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.001 0.401 . . . . 0.0 110.552 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 30.9 m -78.48 162.18 26.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.846 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.2 mtmp? -81.54 141.38 33.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.723 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -54.51 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.96 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.79 -41.65 0.69 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 7.9 pt-20 -87.82 -176.31 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 110.973 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -132.63 144.78 50.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 111.304 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.485 HG13 HD12 ' A' ' 26' ' ' LEU . 25.1 t -73.3 139.5 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 32.1 mmt180 -118.77 -31.51 4.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.11 -143.62 5.84 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.828 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.3 p -136.62 148.26 47.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.647 0.224 . . . . 0.0 110.409 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -160.27 98.33 1.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 151.45 24.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.709 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 20.0 pt -59.0 122.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.663 0.231 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 14.2 ptt-85 61.93 24.4 14.52 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.549 1.14 . . . . 0.0 111.734 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.11 140.37 52.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.926 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.3 pt? -126.39 153.06 45.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.442 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.15 121.8 24.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.19 139.37 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.852 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.8 m -133.11 124.94 18.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.89 147.21 84.8 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.045 2.497 . . . . 0.0 112.709 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -80.97 -41.0 23.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.491 -1.243 . . . . 0.0 108.471 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -161.18 153.87 20.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.09 123.76 3.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.6 m -150.66 143.29 24.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -153.86 160.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.096 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.8 m -88.05 110.64 20.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.996 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.57 134.76 15.11 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.59 118.48 23.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 110.23 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 24' ' ' ARG . . . 79.64 -41.2 2.31 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -175.09 144.68 0.76 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.765 0.282 . . . . 0.0 110.788 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 58.0 m -84.95 -178.54 6.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -81.69 142.43 32.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -64.15 86.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.289 0.566 . . . . 0.0 111.166 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.83 -19.07 0.57 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 83.5 mt-10 -78.48 148.31 33.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -85.24 115.54 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.0 138.57 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.9 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.633 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 55.9 mtp85 -115.09 -43.56 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.785 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.88 -171.48 43.38 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.682 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 p -88.91 143.86 26.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.017 0.409 . . . . 0.0 110.899 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.8 p -145.39 44.4 1.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.0 111.735 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.62 168.63 13.75 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 pt -63.91 109.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 110.098 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 11.0 tpt180 65.3 26.99 12.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.874 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 5.5 m-85 -113.15 135.12 54.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.182 0.515 . . . . 0.0 110.158 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -121.16 125.74 47.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.744 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 t80 -79.03 119.58 22.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -137.18 142.3 42.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 111.222 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 76.8 m -103.37 104.7 42.77 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 72.0 Cg_endo -81.93 138.47 10.37 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.574 2.183 . . . . 0.0 114.574 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.814 ' H ' ' HD3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.62 -19.45 32.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.971 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 16.7 ttm180 . . . . . 0 C--O 1.256 1.435 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.304 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 29' ' ' CYS . 24.6 tp -158.57 154.59 26.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -76.38 55.64 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.969 0.414 . . . . 0.0 111.538 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.2 m -78.69 137.38 37.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.84 160.27 27.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -80.52 117.16 21.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.193 0.521 . . . . 0.0 112.157 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.29 139.69 14.89 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.09 129.0 37.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.025 0.44 . . . . 0.0 110.023 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -48.56 3.88 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.449 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.0 p80 179.27 160.4 0.72 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.801 0.3 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 163.18 25.68 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -94.14 153.25 18.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -49.71 108.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.09 -27.05 4.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.429 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.998 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 94.8 mt-10 -87.71 135.55 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.835 0.35 . . . . 0.0 110.613 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -91.94 125.76 36.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.25 134.98 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -110.61 -34.83 6.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.131 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.09 -152.48 14.87 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.4 p -118.62 138.8 52.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.047 0.424 . . . . 0.0 111.144 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -93.01 -37.13 12.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 110.279 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.02 14.84 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.63 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.48 114.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 111.504 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 63.44 21.78 12.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.723 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.94 136.64 51.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.146 0.498 . . . . 0.0 111.086 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.0 mp -128.54 147.2 50.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.353 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.95 122.84 27.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.48 136.46 54.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.976 0.417 . . . . 0.0 111.667 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.582 ' HB3' HD23 ' A' ' 2' ' ' LEU . 90.9 m -129.43 96.78 26.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 32.2 Cg_endo -63.6 156.95 53.96 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HE ' ' N ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -60.8 -20.46 61.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.404 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' N ' ' HE ' ' A' ' 31' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.92 138.49 48.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -77.82 145.95 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.958 0.409 . . . . 0.0 110.908 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.07 150.68 43.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.189 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.87 167.75 28.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.958 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 72.0 m -79.52 104.6 10.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.41 -178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.78 26.89 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.69 108.37 17.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.8 -40.71 1.4 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.43 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -167.67 163.61 14.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 32.2 m -78.46 161.3 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.463 . . . . 0.0 110.522 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.51 157.94 15.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.265 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -52.52 120.32 5.48 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.04 10.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.524 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 1.012 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 78.5 mt-10 -86.49 130.73 34.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.708 0.289 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.39 121.65 39.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.27 132.26 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -102.6 -43.37 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.113 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.41 -135.38 3.66 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -89.55 139.84 30.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.981 0.391 . . . . 0.0 110.823 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.21 -42.56 5.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.254 0.55 . . . . 0.0 110.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.75 21.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 pt -62.04 110.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.288 0.566 . . . . 0.0 110.912 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 59.87 27.97 17.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.199 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 25.9 m-85 -123.81 138.29 54.53 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -99.66 136.7 39.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.806 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.05 114.31 19.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.1 m -123.22 135.78 54.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 111.739 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 m -128.57 100.61 21.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.197 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.012 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 43.4 Cg_endo -69.56 141.38 45.88 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.539 2.159 . . . . 0.0 113.646 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 31' ' ' ARG . 2.7 tpm_? -120.75 75.44 1.13 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.685 0.755 . . . . 0.0 109.989 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 32' ' ' ARG . 13.8 ttp85 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.749 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.827 HD23 ' H ' ' A' ' 2' ' ' LEU . 1.6 pt? -78.04 51.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 111.376 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.43 57.95 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.302 0.572 . . . . 0.0 109.934 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 56.6 m -67.38 139.84 57.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.017 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.01 174.88 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 95.6 m -83.07 112.54 19.89 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.51 130.87 9.99 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -74.4 101.39 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.35 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.12 -32.62 0.93 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.718 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -167.15 151.56 6.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.928 0.364 . . . . 0.0 110.338 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 63.5 m -79.57 166.05 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.936 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -79.39 145.53 33.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.612 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -64.98 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.33 0.586 . . . . 0.0 111.341 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.12 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.489 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 1.7 pt-20 -99.32 157.35 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 111.271 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -93.63 137.13 33.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.875 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG22 ' SG ' ' A' ' 11' ' ' CYS . 37.4 t -82.69 118.94 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 46.0 tpt85 -89.94 -35.92 15.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.663 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.25 -137.22 4.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.678 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -90.88 142.35 27.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.52 0.2 . . . . 0.0 110.959 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -113.0 -40.64 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.127 0.489 . . . . 0.0 109.884 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.33 -157.85 17.71 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.5 111.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 58.61 26.77 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.877 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 24.1 m-85 -124.04 137.3 54.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.5 145.93 30.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.021 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -79.44 108.72 13.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 12.8 m -110.03 131.61 54.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.382 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -122.77 106.81 34.18 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 35.4 Cg_endo -66.69 143.65 68.79 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.148 2.565 . . . . 0.0 113.597 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 9.1 ttp180 -163.26 -38.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.579 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 51.3 mtp180 . . . . . 0 C--O 1.246 0.869 0 O-C-N 123.902 0.751 . . . . 0.0 110.08 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.92 76.62 4.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.224 0.535 . . . . 0.0 110.102 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.606 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 5.0 tt -123.15 125.24 44.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.43 147.24 28.03 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.0 155.68 29.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.794 0.33 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.77 107.07 16.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.944 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.04 139.27 24.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -89.92 117.13 28.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.45 -43.78 2.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -165.68 146.75 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 61.7 m -86.49 -163.85 0.96 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.602 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -79.85 149.89 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.624 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -67.25 117.78 9.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 1.07 60.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.035 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 5.5 tt0 -78.7 149.21 32.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.6 mmm-85 -98.23 121.1 39.75 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.549 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.4 138.11 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -111.45 -39.88 4.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.578 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.7 178.61 44.71 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -89.23 138.97 30.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.158 0.479 . . . . 0.0 110.891 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 67.7 m -92.76 -39.09 11.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.071 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.8 -154.92 19.78 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.1 113.88 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.199 0.524 . . . . 0.0 111.233 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 64.57 21.47 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.725 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 3.8 m-85 -121.54 134.87 55.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.029 0.442 . . . . 0.0 111.006 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -131.98 128.25 38.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.661 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 t80 -81.99 120.26 25.03 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 79.0 m -135.27 150.87 50.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 111.403 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.9 m -124.15 115.72 27.4 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.546 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 59.0 Cg_endo -80.54 139.55 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 113.847 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -81.06 -24.18 38.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 . . . . . 0 C--O 1.243 0.719 0 CA-C-N 114.328 -1.306 . . . . 0.0 107.802 179.261 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.0 mt -36.9 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.809 0.946 . . . . 0.0 112.808 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.14 63.81 2.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 62.9 m -56.68 137.05 54.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.634 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.95 164.44 34.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.4 t -79.36 103.4 9.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.798 0.332 . . . . 0.0 111.018 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.11 136.15 19.04 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -91.89 115.88 28.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.73 0.3 . . . . 0.0 111.096 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' A' ' 24' ' ' ARG . . . 75.76 -43.48 1.65 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.088 -0.577 . . . . 0.0 114.338 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -172.49 148.84 2.06 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.519 0.659 . . . . 0.0 111.317 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 17' ' ' VAL . 35.4 m -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.457 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 56.5 tptt -79.17 134.94 36.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.398 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -58.38 97.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.941 0.4 . . . . 0.0 110.239 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.36 0.67 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 15.9 pt-20 -86.86 167.38 14.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -112.39 133.97 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' SG ' ' A' ' 11' ' ' CYS . 36.3 t -73.11 131.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.102 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' A' ' 27' ' ' TYR . 58.9 ttm-85 -93.13 -38.03 11.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.918 0.389 . . . . 0.0 110.174 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.76 -160.64 28.07 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -89.71 142.81 27.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.743 0.306 . . . . 0.0 111.506 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.9 t -104.46 -42.65 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.031 0.443 . . . . 0.0 110.09 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.83 -152.53 11.38 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 pt -63.9 110.57 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 54.4 ttm-85 59.89 25.75 14.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.08 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.11 142.57 51.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.745 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.2 pt? -140.52 147.9 40.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 1.2 t80 -79.9 121.73 25.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 17.3 m -113.14 143.04 45.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.931 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -127.37 103.61 22.55 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.74 0.305 . . . . 0.0 110.242 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.698 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 42.0 Cg_endo -67.54 156.69 65.05 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.186 2.59 . . . . 0.0 112.41 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -78.43 55.73 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.2 mt 60.62 44.75 11.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.937 0.433 . . . . 0.0 111.482 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.84 140.59 36.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.469 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.49 145.5 55.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.281 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.4 165.79 33.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 93.5 m -85.79 106.67 17.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.941 0.4 . . . . 0.0 110.845 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -72.33 151.58 46.98 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.765 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -86.35 92.17 8.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.73 -38.61 1.93 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.213 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -155.29 149.22 25.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.57 ' SG ' HG12 ' A' ' 17' ' ' VAL . 25.1 m -79.2 179.69 7.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -79.49 140.0 37.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -63.48 74.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.383 0.611 . . . . 0.0 111.845 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.75 -35.47 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.184 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 3.6 pt-20 -83.75 -178.33 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.881 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 15' ' ' GLU . 1.4 mpt_? -125.5 140.78 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 111.322 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG12 ' SG ' ' A' ' 11' ' ' CYS . 33.7 m -72.3 149.74 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 28.2 mmm180 -125.68 -33.17 2.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.61 -151.93 10.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.604 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.1 p -129.39 141.41 51.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.838 0.319 . . . . 0.0 110.715 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.725 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.3 m -97.29 -38.27 9.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.628 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.21 -154.89 22.45 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.053 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 17.2 pt -61.57 112.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.444 0.64 . . . . 0.0 111.063 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.9 mmt-85 64.5 31.7 12.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.168 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 41.5 m-85 -140.86 136.78 32.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.153 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.7 pt? -143.91 151.26 39.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.74 123.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.8 m -124.54 139.31 53.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 95.1 m -127.27 115.4 21.58 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 6.0 Cg_exo -78.29 140.02 17.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.318 2.679 . . . . 0.0 111.441 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -116.82 -16.3 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.197 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 32' ' ' ARG . 3.5 ptm180 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 2' ' ' LEU . 1.6 pt? -65.75 113.48 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 110.476 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 tm? -167.63 125.59 1.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 81.0 m -77.82 139.16 39.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.629 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -157.28 161.27 39.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.203 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 21.0 t -79.28 105.87 10.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.28 142.14 21.93 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.328 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -91.86 120.34 32.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.03 -52.27 2.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.385 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.32 155.28 0.5 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.202 0.501 . . . . 0.0 111.848 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.571 ' SG ' HD22 ' A' ' 26' ' ' LEU . 3.3 m -79.2 169.96 17.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.686 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.656 ' HG2' ' OE2' ' A' ' 15' ' ' GLU . 28.4 mmtt -81.61 160.85 23.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -66.84 72.19 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.006 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.39 -26.12 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.375 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.954 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.4 mt-10 -79.17 145.88 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.311 . . . . 0.0 110.384 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -83.62 125.62 32.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.011 HG23 HD21 ' A' ' 26' ' ' LEU . 3.7 p -76.47 132.96 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 27' ' ' TYR . 27.0 mmm180 -113.03 -44.69 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.452 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.38 -145.95 10.26 Favored Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.378 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -107.02 143.01 35.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.018 0.409 . . . . 0.0 110.683 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 7.8 p -122.14 11.14 10.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 111.057 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.93 -173.5 36.62 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 pt -65.28 114.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.388 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 63.18 23.67 14.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.964 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 22.7 m-30 -115.14 138.36 50.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.345 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.011 HD21 HG23 ' A' ' 17' ' ' VAL . 5.4 tt -122.51 136.17 54.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 2.7 t80 -78.13 117.76 19.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 57.1 m -109.05 140.72 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.029 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.26 80.33 19.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.954 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 19.7 Cg_endo -57.73 151.47 55.5 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.9 2.4 . . . . 0.0 112.635 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 21.21 17.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.961 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.484 1.867 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 10.3 mp 70.83 149.57 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.066 0.509 . . . . 0.0 111.025 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 63.15 4.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 48.7 m -66.14 137.45 57.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.591 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.94 160.82 40.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.789 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.41 118.32 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.078 0.466 . . . . 0.0 111.943 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -90.04 154.8 24.0 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.377 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.61 108.73 19.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 111.474 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.66 -40.32 0.95 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.95 154.03 17.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.068 0.434 . . . . 0.0 110.919 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.6 m -79.12 161.96 26.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.087 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD3' ' OE2' ' A' ' 15' ' ' GLU . 1.6 tttt -80.19 152.8 28.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.702 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -52.99 132.24 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.052 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 32' ' ' ARG . . . 100.6 -26.49 24.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.59 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 21.9 mt-10 -82.36 149.59 27.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -108.67 129.52 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 p -66.75 130.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.26 0.553 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 7.8 tpm_? -97.07 -40.91 8.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.87 -160.77 33.4 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.784 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.5 p -89.57 143.11 27.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.946 0.373 . . . . 0.0 111.363 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 52.3 t -110.33 -41.25 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.969 0.414 . . . . 0.0 110.29 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.99 -157.69 23.89 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.8 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.816 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -64.16 109.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.5 0.667 . . . . 0.0 110.542 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 62.51 30.5 17.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.059 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 29.1 m-85 -131.52 139.42 49.27 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.499 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 7' ' ' GLY . 2.6 pt? -140.49 143.64 35.59 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.3 t80 -78.3 123.28 26.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 55.9 m -121.5 140.0 52.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.192 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -120.43 96.72 49.03 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 33.9 Cg_endo -66.5 135.09 37.94 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.732 2.288 . . . . 0.0 114.353 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 31' ' ' ARG . 27.4 tpt85 -119.85 -16.74 8.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.495 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 39.1 mmt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.19 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.7 mt 70.99 136.19 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.306 0.651 . . . . 0.0 111.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.1 60.94 4.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.747 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.0 m -62.58 138.45 58.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.98 163.26 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 70.0 m -91.75 107.93 19.55 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.873 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 148.24 40.46 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.073 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -83.84 108.72 17.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.632 0.253 . . . . 0.0 110.395 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.17 -43.16 1.72 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.865 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.09 142.06 3.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.582 0.229 . . . . 0.0 110.518 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.5 m -84.08 174.29 10.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.2 142.16 34.96 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -60.32 109.13 0.92 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.36 -26.61 2.28 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 1.017 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 41.4 mt-10 -78.8 139.16 38.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.269 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -82.95 97.9 8.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' SG ' ' A' ' 28' ' ' CYS . 39.4 t -60.92 127.89 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -95.88 -39.68 9.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.485 . . . . 0.0 109.728 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.9 -153.92 23.13 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.546 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -88.87 140.0 29.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.72 0.295 . . . . 0.0 111.042 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.3 t -93.87 -42.69 8.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.287 0.565 . . . . 0.0 110.004 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.21 -152.41 14.6 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 16.9 pt -58.6 116.05 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.775 0.287 . . . . 0.0 110.323 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 15.4 ptm180 49.9 29.24 3.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 112.137 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 3.5 m-30 -122.45 137.89 54.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 21.7 tp -117.69 132.35 56.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.644 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.64 120.79 34.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 17' ' ' VAL . 56.5 m -137.03 154.3 50.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.034 0.445 . . . . 0.0 111.724 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 81.4 m -123.52 91.68 49.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.558 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 29.2 Cg_endo -64.4 138.41 60.21 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.496 2.131 . . . . 0.0 112.661 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -71.1 -67.64 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.755 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 32' ' ' ARG . 5.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.054 0.846 . . . . 0.0 111.528 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 29' ' ' CYS . 48.0 tp 74.62 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 110.623 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -162.92 78.2 0.46 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 32.5 m -60.93 138.91 58.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.063 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.75 157.31 43.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -85.97 115.48 23.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.468 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 11' ' ' CYS . . . -85.19 135.71 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -86.39 114.49 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.029 0.442 . . . . 0.0 110.38 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.52 3.69 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.061 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 179.58 137.58 0.11 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.397 . . . . 0.0 110.301 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 38.4 m -80.2 -154.47 0.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 10.1 mmpt? -106.39 152.31 23.76 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -68.36 63.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.799 0.809 . . . . 0.0 110.558 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.78 -35.77 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.371 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.887 ' HG3' ' HB3' ' A' ' 30' ' ' PRO . 2.4 mp0 -79.9 138.3 37.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.061 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.47 128.03 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 127.62 30.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.291 0.567 . . . . 0.0 110.606 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -103.36 -33.98 8.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.059 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.63 -152.78 20.4 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 14.1 p -116.43 139.74 50.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.848 0.324 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.1 m -92.57 -38.49 11.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.01 -153.99 14.16 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.793 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.25 113.06 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.57 . . . . 0.0 111.628 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 60.91 27.1 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.244 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.34 136.0 49.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.817 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.3 mp -125.48 142.02 51.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -83.75 121.48 27.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 70.1 m -127.17 135.04 50.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 111.689 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 72.9 m -110.15 104.21 55.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.769 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.887 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 72.8 Cg_endo -76.6 146.45 27.16 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.908 2.405 . . . . 0.0 114.038 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.35 57.69 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.956 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 3.2 tpm_? . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.521 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.4 mt . . . . . 0 CA--C 1.519 -0.218 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.25 140.61 50.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.75 156.06 30.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.4 m -79.58 115.11 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.295 0.569 . . . . 0.0 111.164 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -79.6 145.83 28.03 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.566 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 25' ' ' PHE . 36.1 mtmm -90.58 115.58 27.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.28 -47.73 2.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.012 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HA ' HD21 ' A' ' 26' ' ' LEU . 26.3 p80 -174.22 153.31 1.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.725 0.262 . . . . 0.0 110.359 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.31 163.29 25.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 1.1 ptmm? -106.56 170.58 7.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -49.52 135.23 18.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.355 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.47 20.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.132 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 57.5 mt-10 -95.18 136.53 35.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.931 0.396 . . . . 0.0 111.367 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -103.36 128.06 50.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.13 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.3 138.2 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.71 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 79.6 mtp180 -135.84 38.69 2.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.96 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.13 -148.16 17.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.885 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 11.9 p -134.75 157.53 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.35 0.26 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 p -154.41 46.22 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.744 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.96 165.36 14.38 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 pt -64.59 112.27 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.119 0.459 . . . . 0.0 109.765 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 67.21 18.35 10.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.499 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 2.8 m-85 -115.18 136.92 52.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.838 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.885 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 pt? -121.36 155.38 34.9 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.251 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.72 121.07 24.27 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.5 m -121.29 128.54 52.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.71 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 75.0 m -124.38 98.03 38.83 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.862 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 74.1 Cg_endo . . . . . 0 N--CA 1.46 -0.448 0 C-N-CA 122.994 2.462 . . . . 0.0 112.911 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.83 144.42 30.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.79 165.61 34.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.56 118.9 24.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.172 0.511 . . . . 0.0 112.12 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.93 143.85 19.95 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.7 110.44 16.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.665 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 24' ' ' ARG . . . 75.88 -41.36 1.47 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.793 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -170.36 159.89 7.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.174 0.487 . . . . 0.0 110.72 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 22.4 m -79.07 162.66 25.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -83.54 153.05 24.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -66.25 74.59 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.491 0.662 . . . . 0.0 111.164 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 -30.05 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.635 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 13.4 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -111.02 141.72 44.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.888 0.375 . . . . 0.0 111.336 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' SG ' ' A' ' 11' ' ' CYS . 29.2 m -64.53 138.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.405 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -113.54 -31.13 6.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.31 -144.56 8.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.8 p -132.49 141.13 48.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.723 0.261 . . . . 0.0 110.406 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 75.0 m -96.53 -38.85 9.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.883 0.373 . . . . 0.0 110.736 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.95 -150.65 11.98 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.912 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.55 113.6 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.244 0.545 . . . . 0.0 111.558 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 9' ' ' GLY . 6.1 tpm_? 62.7 19.78 11.62 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.885 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 7.6 m-85 -122.9 134.54 54.36 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.631 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.8 mp -125.57 144.52 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.298 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.61 127.69 33.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 m -129.44 146.74 51.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.706 0.289 . . . . 0.0 111.367 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 57.6 m -136.84 115.12 10.26 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 14.1 Cg_exo . . . . . 0 C--O 1.234 0.299 0 C-N-CA 123.062 2.508 . . . . 0.0 112.266 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -75.43 142.07 43.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.845 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.71 160.22 43.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.967 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -79.7 108.75 13.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.96 0.41 . . . . 0.0 111.192 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.85 140.88 24.66 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -90.2 115.65 27.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 110.521 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.1 -43.66 2.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.493 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' HD21 ' A' ' 26' ' ' LEU . 21.5 p-80 -173.5 155.23 2.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.027 0.413 . . . . 0.0 110.761 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 15.7 m -78.34 164.15 25.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.625 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -78.93 150.57 32.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.638 0.256 . . . . 0.0 110.389 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -64.98 74.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.941 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.39 -29.99 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.625 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 16.1 pt-20 -96.44 -173.58 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 16' ' ' ARG . 3.4 ptp85 -131.8 142.87 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.901 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.59 143.0 13.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -150.55 39.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.874 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.5 29.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.593 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.825 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.6 p -141.83 144.25 33.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.6 m -119.08 37.48 4.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 111.171 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 -173.39 22.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.115 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 pt -61.2 119.2 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.833 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 70.39 24.29 4.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.685 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.656 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 51.7 m-85 -139.5 140.93 37.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.825 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.2 pt? -144.8 152.62 40.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.62 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 124.83 28.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -121.79 142.41 50.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.882 0.373 . . . . 0.0 111.065 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 39.8 m -135.35 118.3 12.71 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.699 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo . . . . . 0 CA--C 1.533 0.459 0 C-N-CA 123.527 2.818 . . . . 0.0 114.229 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 3.6 mm? . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.752 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 17.9 m -71.51 141.79 50.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -128.59 158.47 38.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.418 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.4 m -82.16 106.6 14.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.071 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.77 137.45 22.39 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -82.11 117.88 22.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.6 2.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.668 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 19.1 p-80 179.74 146.64 0.22 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.788 0.294 . . . . 0.0 110.578 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 32.0 m -79.87 -176.14 5.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -151.46 -170.4 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 -64.65 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.75 -33.23 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 1.3 pm0 -125.35 153.12 43.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.49 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.11 122.38 40.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.898 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.508 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 p -69.66 136.22 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.752 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 83.7 mtp180 -126.63 -28.29 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.558 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.68 -159.69 23.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.891 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.7 p -108.54 141.35 40.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.614 0.245 . . . . 0.0 110.9 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.4 t -89.11 -42.84 11.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.179 0.514 . . . . 0.0 109.973 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.6 -156.28 20.5 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 18.3 pt -62.75 113.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.134 0.493 . . . . 0.0 111.008 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 66.12 26.71 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.383 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 38.4 m-85 -137.22 137.41 39.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.253 0.549 . . . . 0.0 110.957 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' HIS . 8.7 mp -114.84 148.47 38.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.88 113.17 25.18 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 51.0 m -138.3 140.17 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.731 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 32.7 m -95.11 114.68 64.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.307 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 64.5 Cg_endo . . . . . 0 C--O 1.234 0.311 0 C-N-CA 123.134 2.556 . . . . 0.0 112.716 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.686 0.279 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 81.8 m -55.74 140.61 41.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.14 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -155.11 154.66 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 98.2 m -78.75 105.59 10.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.087 0.47 . . . . 0.0 110.607 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.88 140.82 32.05 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -82.59 116.42 21.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.16 -41.82 2.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.805 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.21 165.21 2.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.776 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 17' ' ' VAL . 9.6 m -78.33 166.41 22.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 4.6 tppt? -78.45 145.4 35.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -68.39 71.09 0.18 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.64 0.734 . . . . 0.0 110.341 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.06 -29.76 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.047 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 14.1 pt-20 -90.16 178.94 6.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.625 0.25 . . . . 0.0 110.975 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -110.4 134.16 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.022 0.439 . . . . 0.0 111.397 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 11' ' ' CYS . 34.3 m -75.12 146.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.767 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 mmt85 -119.77 -41.88 2.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.13 -142.24 6.76 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.722 HG22 ' HG ' ' A' ' 26' ' ' LEU . 17.7 p -127.24 139.99 52.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.008 0.404 . . . . 0.0 111.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 72.5 m -93.3 -38.12 11.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.99 -154.16 18.81 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.0 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -61.77 116.28 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.219 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 44.4 ttp180 64.06 24.55 13.56 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.399 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 35.5 m-85 -138.07 136.12 36.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 111.068 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.722 ' HG ' HG22 ' A' ' 20' ' ' THR . 7.4 mp -128.89 147.81 50.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.388 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.47 122.82 27.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.6 m -132.97 155.37 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.486 0.184 . . . . 0.0 111.123 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 60.9 m -139.11 113.62 8.25 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.323 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 18.4 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 123.224 2.616 . . . . 0.0 113.058 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.521 -0.171 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -68.91 141.01 55.13 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.401 0.438 . . . . 0.0 111.484 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.56 153.95 32.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.658 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.03 116.16 20.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 112.159 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.61 148.53 23.83 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -90.08 122.01 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.826 0.346 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.88 -43.27 1.92 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.576 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -174.9 157.1 2.34 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.257 0.529 . . . . 0.0 111.013 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 58.3 m -79.06 163.51 25.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.373 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 35.0 mtmm -86.52 147.52 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.251 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -63.82 82.62 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.434 0.635 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.48 -33.06 0.16 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 5.5 pt-20 -96.67 154.88 17.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.802 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.32 141.86 34.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.75 143.39 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.509 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -48.04 2.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.562 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.77 -174.95 46.46 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' HD12 ' A' ' 26' ' ' LEU . 15.3 p -89.64 139.51 30.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.562 0.681 . . . . 0.0 111.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 96.2 m -97.84 -42.56 7.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.144 0.497 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.26 -156.17 23.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.447 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 pt -62.19 112.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.212 0.53 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 66.13 24.56 10.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.742 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 17.9 m-85 -130.14 136.19 49.02 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 20' ' ' THR . 20.4 tp -132.58 137.96 47.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 119.16 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.37 139.69 50.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.73 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 82.3 m -124.19 103.59 32.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.782 0.325 . . . . 0.0 110.603 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.831 2.354 . . . . 0.0 111.418 179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.954 0.407 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.0 m -76.15 141.99 41.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.678 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.25 166.26 33.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.714 0.292 . . . . 0.0 110.596 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 47.7 t -79.56 118.61 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.571 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 138.29 13.9 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 7.8 mtpm? -91.16 118.22 30.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.544 0.211 . . . . 0.0 110.927 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.49 -44.74 2.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.479 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -172.39 157.73 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.959 0.38 . . . . 0.0 110.422 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 35.5 m -78.4 164.76 24.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -87.62 152.79 21.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -52.15 116.91 2.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.916 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.38 -26.18 7.86 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.845 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 1.119 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 76.5 mt-10 -85.69 136.37 33.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.622 -0.289 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -100.31 131.37 46.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.86 129.12 29.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 110.505 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.8 tmm_? -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.527 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -156.64 25.4 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.928 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -89.11 150.7 22.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.795 0.331 . . . . 0.0 111.494 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.1 t -119.7 -41.83 2.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.71 -156.74 18.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -65.58 111.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.388 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' C ' ' HD1' ' A' ' 25' ' ' PHE . 62.5 mmt-85 62.0 22.67 13.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.438 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HD1' ' C ' ' A' ' 24' ' ' ARG . 4.7 m-30 -122.92 142.23 51.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.672 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.5 pt? -139.1 148.95 43.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HE ' ' A' ' 18' ' ' ARG . 1.9 t80 -79.58 126.42 30.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.6 m -117.82 136.93 53.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.758 0.313 . . . . 0.0 111.23 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.3 92.92 47.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.349 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.119 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 42.5 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 C-N-CA 122.595 2.197 . . . . 0.0 112.794 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.433 HD23 ' HG2' ' A' ' 30' ' ' PRO . 54.6 tp . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.93 144.02 16.06 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -160.54 162.53 32.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 15.2 t -86.02 119.93 26.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.176 0.512 . . . . 0.0 111.592 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.09 135.45 13.22 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -87.24 118.41 26.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.46 1.87 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -171.36 157.21 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' HG12 ' A' ' 17' ' ' VAL . 60.1 m -78.49 169.94 17.45 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.489 0.493 . . . . 0.0 110.362 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 28.2 ttmt -78.77 141.34 37.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -61.31 90.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.03 -35.73 0.72 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 5.1 pt-20 -88.3 172.11 9.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.85 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -118.84 144.6 46.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.529 HG12 ' SG ' ' A' ' 11' ' ' CYS . 28.5 m -69.02 138.48 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 80.5 ttt180 -115.68 -28.28 6.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.413 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.84 -154.08 15.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.786 HG22 ' HG ' ' A' ' 26' ' ' LEU . 16.1 p -132.27 140.68 48.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.745 0.273 . . . . 0.0 110.641 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 4.6 m -93.14 -37.88 11.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.183 0.516 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.07 -152.21 13.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.585 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.21 114.93 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.125 0.488 . . . . 0.0 111.283 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 64.94 22.97 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.607 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 7.9 m-85 -128.67 134.63 48.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.497 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 20' ' ' THR . 6.7 mp -133.6 142.72 48.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.982 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' A' ' 18' ' ' ARG . 2.7 t80 -81.52 129.5 34.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 m -129.33 147.08 51.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.021 0.439 . . . . 0.0 111.63 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 74.9 m -135.02 118.22 13.01 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 18.3 Cg_exo . . . . . 0 C--O 1.233 0.259 0 C-N-CA 123.192 2.594 . . . . 0.0 113.623 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 121.064 0.459 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 87.3 m -76.3 141.57 41.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.56 157.11 29.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 58.9 m -80.36 113.64 18.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.085 0.469 . . . . 0.0 110.961 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -80.03 144.03 25.78 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.504 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 15.7 ptpt -86.12 113.49 22.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 110.966 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.37 -40.28 1.28 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.636 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -170.36 156.67 5.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.001 0.401 . . . . 0.0 110.552 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 30.9 m -78.48 162.18 26.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.846 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.2 mtmp? -81.54 141.38 33.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.723 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -54.51 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.96 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.79 -41.65 0.69 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 7.9 pt-20 -87.82 -176.31 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 110.973 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -132.63 144.78 50.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 111.304 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.485 HG13 HD12 ' A' ' 26' ' ' LEU . 25.1 t -73.3 139.5 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 32.1 mmt180 -118.77 -31.51 4.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.11 -143.62 5.84 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.828 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.3 p -136.62 148.26 47.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.647 0.224 . . . . 0.0 110.409 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -160.27 98.33 1.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 151.45 24.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.709 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 20.0 pt -59.0 122.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.663 0.231 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 14.2 ptt-85 61.93 24.4 14.52 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.549 1.14 . . . . 0.0 111.734 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.11 140.37 52.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.926 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.3 pt? -126.39 153.06 45.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.442 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.15 121.8 24.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.19 139.37 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.852 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.8 m -133.11 124.94 18.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--O 1.233 0.252 0 C-N-CA 123.045 2.497 . . . . 0.0 112.709 -179.522 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.463 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.6 m -150.66 143.29 24.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -153.86 160.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.096 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.8 m -88.05 110.64 20.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.996 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.57 134.76 15.11 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.59 118.48 23.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 110.23 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 24' ' ' ARG . . . 79.64 -41.2 2.31 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -175.09 144.68 0.76 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.765 0.282 . . . . 0.0 110.788 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 58.0 m -84.95 -178.54 6.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -81.69 142.43 32.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -64.15 86.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.289 0.566 . . . . 0.0 111.166 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.83 -19.07 0.57 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 83.5 mt-10 -78.48 148.31 33.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -85.24 115.54 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.0 138.57 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.9 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.633 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 55.9 mtp85 -115.09 -43.56 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.785 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.88 -171.48 43.38 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.682 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 p -88.91 143.86 26.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.017 0.409 . . . . 0.0 110.899 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.8 p -145.39 44.4 1.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.0 111.735 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.62 168.63 13.75 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 pt -63.91 109.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 110.098 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 11.0 tpt180 65.3 26.99 12.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.874 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 5.5 m-85 -113.15 135.12 54.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.182 0.515 . . . . 0.0 110.158 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -121.16 125.74 47.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.744 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 t80 -79.03 119.58 22.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -137.18 142.3 42.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 111.222 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 76.8 m -103.37 104.7 42.77 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 72.0 Cg_endo . . . . . 0 N--CA 1.453 -0.911 0 C-N-CA 122.574 2.183 . . . . 0.0 114.574 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.969 0.414 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.2 m -78.69 137.38 37.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.84 160.27 27.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -80.52 117.16 21.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.193 0.521 . . . . 0.0 112.157 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.29 139.69 14.89 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.09 129.0 37.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.025 0.44 . . . . 0.0 110.023 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -48.56 3.88 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.449 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.0 p80 179.27 160.4 0.72 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.801 0.3 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 163.18 25.68 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -94.14 153.25 18.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -49.71 108.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.09 -27.05 4.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.429 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.998 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 94.8 mt-10 -87.71 135.55 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.835 0.35 . . . . 0.0 110.613 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -91.94 125.76 36.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.25 134.98 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -110.61 -34.83 6.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.131 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.09 -152.48 14.87 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.4 p -118.62 138.8 52.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.047 0.424 . . . . 0.0 111.144 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -93.01 -37.13 12.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 110.279 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.02 14.84 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.63 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.48 114.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 111.504 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 63.44 21.78 12.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.723 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.94 136.64 51.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.146 0.498 . . . . 0.0 111.086 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.0 mp -128.54 147.2 50.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.353 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.95 122.84 27.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.48 136.46 54.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.976 0.417 . . . . 0.0 111.667 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 90.9 m -129.43 96.78 26.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 32.2 Cg_endo . . . . . 0 N--CA 1.464 -0.228 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.958 0.409 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.07 150.68 43.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.189 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.87 167.75 28.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.958 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 72.0 m -79.52 104.6 10.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.41 -178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.78 26.89 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.69 108.37 17.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.8 -40.71 1.4 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.43 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -167.67 163.61 14.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 32.2 m -78.46 161.3 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.463 . . . . 0.0 110.522 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.51 157.94 15.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.265 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -52.52 120.32 5.48 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.04 10.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.524 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 1.012 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 78.5 mt-10 -86.49 130.73 34.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.708 0.289 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.39 121.65 39.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.27 132.26 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -102.6 -43.37 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.113 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.41 -135.38 3.66 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -89.55 139.84 30.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.981 0.391 . . . . 0.0 110.823 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.21 -42.56 5.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.254 0.55 . . . . 0.0 110.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.75 21.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 pt -62.04 110.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.288 0.566 . . . . 0.0 110.912 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 59.87 27.97 17.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.199 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 25.9 m-85 -123.81 138.29 54.53 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -99.66 136.7 39.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.806 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.05 114.31 19.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.1 m -123.22 135.78 54.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 111.739 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 m -128.57 100.61 21.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.197 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.012 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 43.4 Cg_endo . . . . . 0 N--CA 1.463 -0.277 0 C-N-CA 122.539 2.159 . . . . 0.0 113.646 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.302 0.572 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 56.6 m -67.38 139.84 57.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.017 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.01 174.88 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 95.6 m -83.07 112.54 19.89 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.51 130.87 9.99 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -74.4 101.39 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.35 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.12 -32.62 0.93 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.718 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -167.15 151.56 6.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.928 0.364 . . . . 0.0 110.338 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 63.5 m -79.57 166.05 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.936 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -79.39 145.53 33.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.612 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -64.98 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.33 0.586 . . . . 0.0 111.341 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.12 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.489 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 1.7 pt-20 -99.32 157.35 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 111.271 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -93.63 137.13 33.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.875 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG22 ' SG ' ' A' ' 11' ' ' CYS . 37.4 t -82.69 118.94 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 46.0 tpt85 -89.94 -35.92 15.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.663 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.25 -137.22 4.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.678 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -90.88 142.35 27.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.52 0.2 . . . . 0.0 110.959 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -113.0 -40.64 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.127 0.489 . . . . 0.0 109.884 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.33 -157.85 17.71 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.5 111.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 58.61 26.77 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.877 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 24.1 m-85 -124.04 137.3 54.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.5 145.93 30.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.021 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -79.44 108.72 13.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 12.8 m -110.03 131.61 54.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.382 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -122.77 106.81 34.18 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 35.4 Cg_endo . . . . . 0 C--O 1.234 0.283 0 C-N-CA 123.148 2.565 . . . . 0.0 113.597 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.606 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 5.0 tt . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.43 147.24 28.03 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.0 155.68 29.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.794 0.33 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.77 107.07 16.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.944 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.04 139.27 24.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -89.92 117.13 28.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.45 -43.78 2.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -165.68 146.75 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 61.7 m -86.49 -163.85 0.96 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.602 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -79.85 149.89 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.624 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -67.25 117.78 9.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 1.07 60.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.035 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 5.5 tt0 -78.7 149.21 32.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.6 mmm-85 -98.23 121.1 39.75 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.549 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.4 138.11 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -111.45 -39.88 4.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.578 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.7 178.61 44.71 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -89.23 138.97 30.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.158 0.479 . . . . 0.0 110.891 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 67.7 m -92.76 -39.09 11.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.071 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.8 -154.92 19.78 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.1 113.88 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.199 0.524 . . . . 0.0 111.233 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 64.57 21.47 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.725 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 3.8 m-85 -121.54 134.87 55.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.029 0.442 . . . . 0.0 111.006 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -131.98 128.25 38.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.661 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 t80 -81.99 120.26 25.03 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 79.0 m -135.27 150.87 50.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 111.403 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.9 m -124.15 115.72 27.4 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.546 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 59.0 Cg_endo . . . . . 0 N--CA 1.457 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 113.847 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.819 0.343 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 62.9 m -56.68 137.05 54.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.634 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.95 164.44 34.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.4 t -79.36 103.4 9.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.798 0.332 . . . . 0.0 111.018 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.11 136.15 19.04 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -91.89 115.88 28.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.73 0.3 . . . . 0.0 111.096 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' A' ' 24' ' ' ARG . . . 75.76 -43.48 1.65 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.088 -0.577 . . . . 0.0 114.338 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -172.49 148.84 2.06 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.519 0.659 . . . . 0.0 111.317 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 17' ' ' VAL . 35.4 m -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.457 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 56.5 tptt -79.17 134.94 36.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.398 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -58.38 97.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.941 0.4 . . . . 0.0 110.239 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.36 0.67 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 15.9 pt-20 -86.86 167.38 14.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -112.39 133.97 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' SG ' ' A' ' 11' ' ' CYS . 36.3 t -73.11 131.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.102 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' A' ' 27' ' ' TYR . 58.9 ttm-85 -93.13 -38.03 11.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.918 0.389 . . . . 0.0 110.174 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.76 -160.64 28.07 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -89.71 142.81 27.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.743 0.306 . . . . 0.0 111.506 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.9 t -104.46 -42.65 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.031 0.443 . . . . 0.0 110.09 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.83 -152.53 11.38 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 pt -63.9 110.57 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 54.4 ttm-85 59.89 25.75 14.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.08 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.11 142.57 51.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.745 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.2 pt? -140.52 147.9 40.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 1.2 t80 -79.9 121.73 25.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 17.3 m -113.14 143.04 45.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.931 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -127.37 103.61 22.55 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.74 0.305 . . . . 0.0 110.242 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.698 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 42.0 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 123.186 2.59 . . . . 0.0 112.41 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.646 0.26 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.49 145.5 55.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.281 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.4 165.79 33.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 93.5 m -85.79 106.67 17.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.941 0.4 . . . . 0.0 110.845 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -72.33 151.58 46.98 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.765 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -86.35 92.17 8.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.73 -38.61 1.93 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.213 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -155.29 149.22 25.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.57 ' SG ' HG12 ' A' ' 17' ' ' VAL . 25.1 m -79.2 179.69 7.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -79.49 140.0 37.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -63.48 74.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.383 0.611 . . . . 0.0 111.845 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.75 -35.47 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.184 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 3.6 pt-20 -83.75 -178.33 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.881 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 15' ' ' GLU . 1.4 mpt_? -125.5 140.78 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 111.322 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG12 ' SG ' ' A' ' 11' ' ' CYS . 33.7 m -72.3 149.74 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 28.2 mmm180 -125.68 -33.17 2.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.61 -151.93 10.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.604 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.1 p -129.39 141.41 51.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.838 0.319 . . . . 0.0 110.715 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.725 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.3 m -97.29 -38.27 9.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.628 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.21 -154.89 22.45 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.053 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.49 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 17.2 pt -61.57 112.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.444 0.64 . . . . 0.0 111.063 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.9 mmt-85 64.5 31.7 12.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.168 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 41.5 m-85 -140.86 136.78 32.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.153 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.7 pt? -143.91 151.26 39.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.74 123.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.8 m -124.54 139.31 53.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 95.1 m -127.27 115.4 21.58 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 6.0 Cg_exo . . . . . 0 N--CA 1.459 -0.53 0 C-N-CA 123.318 2.679 . . . . 0.0 111.441 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 tm? . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 81.0 m -77.82 139.16 39.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.629 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -157.28 161.27 39.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.203 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 21.0 t -79.28 105.87 10.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.28 142.14 21.93 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.328 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -91.86 120.34 32.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.03 -52.27 2.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.385 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.32 155.28 0.5 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.202 0.501 . . . . 0.0 111.848 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.571 ' SG ' HD22 ' A' ' 26' ' ' LEU . 3.3 m -79.2 169.96 17.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.686 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.656 ' HG2' ' OE2' ' A' ' 15' ' ' GLU . 28.4 mmtt -81.61 160.85 23.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -66.84 72.19 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.006 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.39 -26.12 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.375 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.954 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.4 mt-10 -79.17 145.88 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.311 . . . . 0.0 110.384 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -83.62 125.62 32.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.011 HG23 HD21 ' A' ' 26' ' ' LEU . 3.7 p -76.47 132.96 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 27' ' ' TYR . 27.0 mmm180 -113.03 -44.69 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.452 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.38 -145.95 10.26 Favored Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.378 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -107.02 143.01 35.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.018 0.409 . . . . 0.0 110.683 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 7.8 p -122.14 11.14 10.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 111.057 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.93 -173.5 36.62 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 pt -65.28 114.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.388 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 63.18 23.67 14.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.964 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 22.7 m-30 -115.14 138.36 50.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.345 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.011 HD21 HG23 ' A' ' 17' ' ' VAL . 5.4 tt -122.51 136.17 54.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 2.7 t80 -78.13 117.76 19.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 57.1 m -109.05 140.72 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.029 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.26 80.33 19.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.954 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 19.7 Cg_endo . . . . . 0 C--O 1.233 0.235 0 C-N-CA 122.9 2.4 . . . . 0.0 112.635 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 48.7 m -66.14 137.45 57.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.591 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.94 160.82 40.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.789 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.41 118.32 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.078 0.466 . . . . 0.0 111.943 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -90.04 154.8 24.0 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.377 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.61 108.73 19.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 111.474 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.66 -40.32 0.95 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.95 154.03 17.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.068 0.434 . . . . 0.0 110.919 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.6 m -79.12 161.96 26.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.087 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD3' ' OE2' ' A' ' 15' ' ' GLU . 1.6 tttt -80.19 152.8 28.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.702 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -52.99 132.24 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.052 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.49 24.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.59 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 21.9 mt-10 -82.36 149.59 27.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -108.67 129.52 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 p -66.75 130.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.26 0.553 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 7.8 tpm_? -97.07 -40.91 8.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.87 -160.77 33.4 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.784 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.5 p -89.57 143.11 27.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.946 0.373 . . . . 0.0 111.363 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 52.3 t -110.33 -41.25 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.969 0.414 . . . . 0.0 110.29 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.99 -157.69 23.89 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.8 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.816 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -64.16 109.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.5 0.667 . . . . 0.0 110.542 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 62.51 30.5 17.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.059 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 29.1 m-85 -131.52 139.42 49.27 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.499 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 7' ' ' GLY . 2.6 pt? -140.49 143.64 35.59 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.3 t80 -78.3 123.28 26.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 55.9 m -121.5 140.0 52.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.192 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -120.43 96.72 49.03 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 33.9 Cg_endo . . . . . 0 C--O 1.233 0.25 0 C-N-CA 122.732 2.288 . . . . 0.0 114.353 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.781 0.325 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.0 m -62.58 138.45 58.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.98 163.26 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 70.0 m -91.75 107.93 19.55 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.873 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 148.24 40.46 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.073 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -83.84 108.72 17.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.632 0.253 . . . . 0.0 110.395 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.17 -43.16 1.72 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.865 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.09 142.06 3.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.582 0.229 . . . . 0.0 110.518 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.5 m -84.08 174.29 10.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.2 142.16 34.96 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -60.32 109.13 0.92 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.36 -26.61 2.28 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 1.017 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 41.4 mt-10 -78.8 139.16 38.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.269 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -82.95 97.9 8.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' SG ' ' A' ' 28' ' ' CYS . 39.4 t -60.92 127.89 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -95.88 -39.68 9.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.485 . . . . 0.0 109.728 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.9 -153.92 23.13 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.546 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -88.87 140.0 29.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.72 0.295 . . . . 0.0 111.042 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.3 t -93.87 -42.69 8.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.287 0.565 . . . . 0.0 110.004 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.21 -152.41 14.6 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 16.9 pt -58.6 116.05 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.775 0.287 . . . . 0.0 110.323 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 15.4 ptm180 49.9 29.24 3.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 112.137 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 3.5 m-30 -122.45 137.89 54.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 21.7 tp -117.69 132.35 56.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.644 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.64 120.79 34.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 17' ' ' VAL . 56.5 m -137.03 154.3 50.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.034 0.445 . . . . 0.0 111.724 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 81.4 m -123.52 91.68 49.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.558 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 29.2 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 C-N-CA 122.496 2.131 . . . . 0.0 112.661 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 32.5 m -60.93 138.91 58.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.063 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.75 157.31 43.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -85.97 115.48 23.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.468 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 11' ' ' CYS . . . -85.19 135.71 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -86.39 114.49 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.029 0.442 . . . . 0.0 110.38 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.52 3.69 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.061 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 179.58 137.58 0.11 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.397 . . . . 0.0 110.301 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 38.4 m -80.2 -154.47 0.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 10.1 mmpt? -106.39 152.31 23.76 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -68.36 63.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.799 0.809 . . . . 0.0 110.558 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.78 -35.77 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.371 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.887 ' HG3' ' HB3' ' A' ' 30' ' ' PRO . 2.4 mp0 -79.9 138.3 37.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.061 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.47 128.03 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 127.62 30.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.291 0.567 . . . . 0.0 110.606 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -103.36 -33.98 8.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.059 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.63 -152.78 20.4 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 14.1 p -116.43 139.74 50.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.848 0.324 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.1 m -92.57 -38.49 11.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.01 -153.99 14.16 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.793 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.25 113.06 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.57 . . . . 0.0 111.628 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 60.91 27.1 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.244 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.34 136.0 49.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.817 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.3 mp -125.48 142.02 51.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -83.75 121.48 27.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 70.1 m -127.17 135.04 50.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 111.689 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 72.9 m -110.15 104.21 55.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.769 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.887 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 72.8 Cg_endo . . . . . 0 C--O 1.232 0.217 0 C-N-CA 122.908 2.405 . . . . 0.0 114.038 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.8 tp -137.36 47.19 2.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.518 0.675 . . . . 0.0 109.85 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.4 mt -139.7 131.17 26.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.675 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.25 140.61 50.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.093 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.75 156.06 30.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.4 m -79.58 115.11 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.295 0.569 . . . . 0.0 111.164 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -79.6 145.83 28.03 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.566 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 25' ' ' PHE . 36.1 mtmm -90.58 115.58 27.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.28 -47.73 2.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.012 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HA ' HD21 ' A' ' 26' ' ' LEU . 26.3 p80 -174.22 153.31 1.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.725 0.262 . . . . 0.0 110.359 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -78.31 163.29 25.84 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 1.1 ptmm? -106.56 170.58 7.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -49.52 135.23 18.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.355 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.82 -27.47 20.43 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.132 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.862 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 57.5 mt-10 -95.18 136.53 35.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.931 0.396 . . . . 0.0 111.367 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -103.36 128.06 50.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.13 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.3 138.2 21.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.71 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 79.6 mtp180 -135.84 38.69 2.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.96 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.13 -148.16 17.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.885 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 11.9 p -134.75 157.53 46.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.35 0.26 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 p -154.41 46.22 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.315 0.578 . . . . 0.0 111.744 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.96 165.36 14.38 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.2 pt -64.59 112.27 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 117.119 0.459 . . . . 0.0 109.765 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.9 mmm-85 67.21 18.35 10.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.499 ' CZ ' ' HG2' ' A' ' 8' ' ' LYS . 2.8 m-85 -115.18 136.92 52.59 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.838 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.885 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 pt? -121.36 155.38 34.9 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.251 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.72 121.07 24.27 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.5 m -121.29 128.54 52.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.847 0.356 . . . . 0.0 110.733 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.71 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 75.0 m -124.38 98.03 38.83 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.862 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 74.1 Cg_endo -76.59 149.09 30.04 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.994 2.462 . . . . 0.0 112.911 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ptm85 -121.88 32.46 5.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.551 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.251 1.145 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.224 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.28 62.67 3.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.06 0.457 . . . . 0.0 110.575 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.7 tp -150.97 135.91 17.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.246 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.8 m -145.83 144.42 30.25 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.79 165.61 34.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.56 118.9 24.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.172 0.511 . . . . 0.0 112.12 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.93 143.85 19.95 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.7 110.44 16.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.665 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' HA2' ' HE ' ' A' ' 24' ' ' ARG . . . 75.88 -41.36 1.47 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.793 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -170.36 159.89 7.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.174 0.487 . . . . 0.0 110.72 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 22.4 m -79.07 162.66 25.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.415 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -83.54 153.05 24.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -66.25 74.59 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.491 0.662 . . . . 0.0 111.164 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.54 -30.05 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.635 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 13.4 pt-20 -101.14 162.79 12.64 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -111.02 141.72 44.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.888 0.375 . . . . 0.0 111.336 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' SG ' ' A' ' 11' ' ' CYS . 29.2 m -64.53 138.21 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.405 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -113.54 -31.13 6.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.951 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.31 -144.56 8.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.8 p -132.49 141.13 48.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.723 0.261 . . . . 0.0 110.406 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 75.0 m -96.53 -38.85 9.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.883 0.373 . . . . 0.0 110.736 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.95 -150.65 11.98 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.912 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -60.55 113.6 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.244 0.545 . . . . 0.0 111.558 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.519 ' HE ' ' HA2' ' A' ' 9' ' ' GLY . 6.1 tpm_? 62.7 19.78 11.62 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.885 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 7.6 m-85 -122.9 134.54 54.36 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.631 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.8 mp -125.57 144.52 50.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.298 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.61 127.69 33.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.5 m -129.44 146.74 51.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.706 0.289 . . . . 0.0 111.367 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 57.6 m -136.84 115.12 10.26 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 14.1 Cg_exo -69.34 144.51 56.51 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.062 2.508 . . . . 0.0 112.266 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -54.69 -52.89 60.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.604 -1.188 . . . . 0.0 109.562 178.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.574 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -87.15 153.07 21.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.866 0.365 . . . . 0.0 111.264 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.2 mt -119.26 121.85 40.59 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -75.43 142.07 43.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.845 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.71 160.22 43.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.967 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.4 m -79.7 108.75 13.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.96 0.41 . . . . 0.0 111.192 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.85 140.88 24.66 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -90.2 115.65 27.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.857 0.361 . . . . 0.0 110.521 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.1 -43.66 2.02 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.493 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' HD21 ' A' ' 26' ' ' LEU . 21.5 p-80 -173.5 155.23 2.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.027 0.413 . . . . 0.0 110.761 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 15.7 m -78.34 164.15 25.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.625 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -78.93 150.57 32.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.638 0.256 . . . . 0.0 110.389 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -64.98 74.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.941 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.39 -29.99 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.625 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 16.1 pt-20 -96.44 -173.58 2.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 16' ' ' ARG . 3.4 ptp85 -131.8 142.87 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.901 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.59 143.0 13.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -150.55 39.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.874 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.5 29.04 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.593 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.825 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 6.6 p -141.83 144.25 33.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.6 m -119.08 37.48 4.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 111.171 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 -173.39 22.71 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.115 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 pt -61.2 119.2 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.833 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 70.39 24.29 4.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.685 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.656 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 51.7 m-85 -139.5 140.93 37.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.825 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.2 pt? -144.8 152.62 40.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.62 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 124.83 28.76 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -121.79 142.41 50.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.882 0.373 . . . . 0.0 111.065 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.415 ' HB3' HD23 ' A' ' 2' ' ' LEU . 39.8 m -135.35 118.3 12.71 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.699 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.495 ' O ' ' HG ' ' A' ' 2' ' ' LEU . 28.3 Cg_exo -63.0 163.84 21.22 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.527 2.818 . . . . 0.0 114.229 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.4 mtt85 -95.05 58.33 2.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.244 -179.508 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.706 ' HG ' HH22 ' A' ' 16' ' ' ARG . 10.0 mp 65.18 40.24 5.07 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.742 0.417 . . . . 0.0 111.483 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 3.6 mm? -91.56 114.39 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.185 -0.462 . . . . 0.0 109.913 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.752 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 17.9 m -71.51 141.79 50.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -128.59 158.47 38.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.418 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.4 m -82.16 106.6 14.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.071 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.77 137.45 22.39 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -82.11 117.88 22.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.08 -46.6 2.15 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.668 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' HD13 ' A' ' 26' ' ' LEU . 19.1 p-80 179.74 146.64 0.22 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.788 0.294 . . . . 0.0 110.578 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 32.0 m -79.87 -176.14 5.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -151.46 -170.4 3.64 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 tpt85 -64.65 66.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -163.75 -33.23 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 1.3 pm0 -125.35 153.12 43.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.972 0.415 . . . . 0.0 110.49 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.706 HH22 ' HG ' ' A' ' 2' ' ' LEU . 0.8 OUTLIER -97.11 122.38 40.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.898 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.508 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 p -69.66 136.22 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.864 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.752 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 83.7 mtp180 -126.63 -28.29 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.558 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.68 -159.69 23.02 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.891 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.7 p -108.54 141.35 40.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.614 0.245 . . . . 0.0 110.9 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.4 t -89.11 -42.84 11.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.179 0.514 . . . . 0.0 109.973 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.6 -156.28 20.5 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 18.3 pt -62.75 113.36 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.134 0.493 . . . . 0.0 111.008 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 66.12 26.71 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.383 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 38.4 m-85 -137.22 137.41 39.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.253 0.549 . . . . 0.0 110.957 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' HIS . 8.7 mp -114.84 148.47 38.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -98.88 113.17 25.18 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 51.0 m -138.3 140.17 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.731 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 32.7 m -95.11 114.68 64.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.307 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 64.5 Cg_endo -72.93 168.6 24.26 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.134 2.556 . . . . 0.0 112.716 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 14' ' ' GLY . 78.9 mtp180 -73.58 52.77 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.224 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.334 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 tp 57.84 45.21 18.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.263 0.554 . . . . 0.0 110.509 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.9 tp -75.27 78.4 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.431 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 81.8 m -55.74 140.61 41.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.14 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -155.11 154.66 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.84 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 98.2 m -78.75 105.59 10.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.087 0.47 . . . . 0.0 110.607 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.88 140.82 32.05 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -82.59 116.42 21.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.16 -41.82 2.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.805 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.21 165.21 2.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.776 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.616 ' SG ' HG12 ' A' ' 17' ' ' VAL . 9.6 m -78.33 166.41 22.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.244 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 4.6 tppt? -78.45 145.4 35.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -68.39 71.09 0.18 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.64 0.734 . . . . 0.0 110.341 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.06 -29.76 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.047 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 14.1 pt-20 -90.16 178.94 6.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.625 0.25 . . . . 0.0 110.975 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -110.4 134.16 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.022 0.439 . . . . 0.0 111.397 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' SG ' ' A' ' 11' ' ' CYS . 34.3 m -75.12 146.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.767 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 15.9 mmt85 -119.77 -41.88 2.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.13 -142.24 6.76 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.722 HG22 ' HG ' ' A' ' 26' ' ' LEU . 17.7 p -127.24 139.99 52.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.008 0.404 . . . . 0.0 111.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 72.5 m -93.3 -38.12 11.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.99 -154.16 18.81 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.0 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -61.77 116.28 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.219 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 44.4 ttp180 64.06 24.55 13.56 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.399 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 35.5 m-85 -138.07 136.12 36.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 111.068 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.722 ' HG ' HG22 ' A' ' 20' ' ' THR . 7.4 mp -128.89 147.81 50.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.388 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.47 122.82 27.46 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 19.6 m -132.97 155.37 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.486 0.184 . . . . 0.0 111.123 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 60.9 m -139.11 113.62 8.25 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.323 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 18.4 Cg_endo -59.89 139.66 89.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.224 2.616 . . . . 0.0 113.058 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -83.15 56.96 3.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.128 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 . . . . . 0 C--O 1.244 0.812 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.723 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.008 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 31' ' ' ARG . 86.5 mt -82.55 43.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.156 0.478 . . . . 0.0 111.084 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.38 139.46 53.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -68.91 141.01 55.13 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.401 0.438 . . . . 0.0 111.484 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.56 153.95 32.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.658 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.03 116.16 20.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 112.159 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.61 148.53 23.83 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -90.08 122.01 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.826 0.346 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.88 -43.27 1.92 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.576 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -174.9 157.1 2.34 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.257 0.529 . . . . 0.0 111.013 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 58.3 m -79.06 163.51 25.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.373 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 35.0 mtmm -86.52 147.52 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.251 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -63.82 82.62 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.434 0.635 . . . . 0.0 110.833 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.48 -33.06 0.16 Allowed Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 5.5 pt-20 -96.67 154.88 17.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.802 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.32 141.86 34.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.956 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.75 143.39 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.509 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.4 -48.04 2.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.562 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.77 -174.95 46.46 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.447 ' HA ' HD12 ' A' ' 26' ' ' LEU . 15.3 p -89.64 139.51 30.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.562 0.681 . . . . 0.0 111.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 96.2 m -97.84 -42.56 7.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.144 0.497 . . . . 0.0 110.328 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.26 -156.17 23.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.447 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 pt -62.19 112.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.212 0.53 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 66.13 24.56 10.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.742 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 17.9 m-85 -130.14 136.19 49.02 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.388 0.613 . . . . 0.0 110.971 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 20' ' ' THR . 20.4 tp -132.58 137.96 47.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.92 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 119.16 21.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.37 139.69 50.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.73 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 82.3 m -124.19 103.59 32.82 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.782 0.325 . . . . 0.0 110.603 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.42 131.91 15.6 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.831 2.354 . . . . 0.0 111.418 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.484 ' HA ' HD22 ' A' ' 2' ' ' LEU . 34.6 ttm-85 -172.52 94.08 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.239 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' OXT' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.404 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 30' ' ' PRO . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.26 63.04 3.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.597 0.237 . . . . 0.0 111.525 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.06 134.09 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 110.522 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.0 m -76.15 141.99 41.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.678 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.25 166.26 33.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.714 0.292 . . . . 0.0 110.596 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 47.7 t -79.56 118.61 21.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.571 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 138.29 13.9 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 7.8 mtpm? -91.16 118.22 30.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.544 0.211 . . . . 0.0 110.927 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.49 -44.74 2.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.479 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -172.39 157.73 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.959 0.38 . . . . 0.0 110.422 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 35.5 m -78.4 164.76 24.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -87.62 152.79 21.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -52.15 116.91 2.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.916 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.38 -26.18 7.86 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.845 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 1.119 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 76.5 mt-10 -85.69 136.37 33.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.622 -0.289 . . . . 0.0 110.696 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -100.31 131.37 46.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.86 129.12 29.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.152 0.501 . . . . 0.0 110.505 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.8 tmm_? -97.66 -37.63 9.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.527 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -156.64 25.4 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.928 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -89.11 150.7 22.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.795 0.331 . . . . 0.0 111.494 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.1 t -119.7 -41.83 2.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.71 -156.74 18.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -65.58 111.39 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.15 0.5 . . . . 0.0 110.388 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' C ' ' HD1' ' A' ' 25' ' ' PHE . 62.5 mmt-85 62.0 22.67 13.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.438 -178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HD1' ' C ' ' A' ' 24' ' ' ARG . 4.7 m-30 -122.92 142.23 51.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.672 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.5 pt? -139.1 148.95 43.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HE ' ' A' ' 18' ' ' ARG . 1.9 t80 -79.58 126.42 30.87 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.6 m -117.82 136.93 53.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.758 0.313 . . . . 0.0 111.23 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.3 92.92 47.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.349 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.119 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 42.5 Cg_endo -75.17 141.38 26.11 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.595 2.197 . . . . 0.0 112.794 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.8 mtt-85 -103.51 39.81 1.53 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.777 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.553 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 1.4 pp -83.26 32.82 0.45 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.132 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.433 HD23 ' HG2' ' A' ' 30' ' ' PRO . 54.6 tp -172.68 128.55 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.744 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.93 144.02 16.06 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -160.54 162.53 32.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.564 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 15.2 t -86.02 119.93 26.85 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.176 0.512 . . . . 0.0 111.592 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.09 135.45 13.22 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -87.24 118.41 26.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.24 -39.46 1.87 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.131 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -171.36 157.21 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' HG12 ' A' ' 17' ' ' VAL . 60.1 m -78.49 169.94 17.45 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.489 0.493 . . . . 0.0 110.362 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 28.2 ttmt -78.77 141.34 37.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.253 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -61.31 90.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.418 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.03 -35.73 0.72 Allowed Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 5.1 pt-20 -88.3 172.11 9.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.85 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -118.84 144.6 46.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG12 ' SG ' ' A' ' 11' ' ' CYS . 28.5 m -69.02 138.48 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 80.5 ttt180 -115.68 -28.28 6.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.413 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.84 -154.08 15.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.786 HG22 ' HG ' ' A' ' 26' ' ' LEU . 16.1 p -132.27 140.68 48.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.745 0.273 . . . . 0.0 110.641 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 4.6 m -93.14 -37.88 11.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.183 0.516 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.07 -152.21 13.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.585 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.21 114.93 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.125 0.488 . . . . 0.0 111.283 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 64.94 22.97 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.607 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 7.9 m-85 -128.67 134.63 48.57 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.497 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.786 ' HG ' HG22 ' A' ' 20' ' ' THR . 6.7 mp -133.6 142.72 48.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.982 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' A' ' 18' ' ' ARG . 2.7 t80 -81.52 129.5 34.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.8 m -129.33 147.08 51.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.021 0.439 . . . . 0.0 111.63 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 74.9 m -135.02 118.22 13.01 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 15' ' ' GLU . 18.3 Cg_exo -67.77 -179.14 1.89 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.192 2.594 . . . . 0.0 113.623 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.02 55.13 1.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.485 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.939 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.58 137.99 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.839 0.32 . . . . 0.0 110.26 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.24 56.38 3.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 87.3 m -76.3 141.57 41.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.56 157.11 29.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.327 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 58.9 m -80.36 113.64 18.69 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.085 0.469 . . . . 0.0 110.961 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -80.03 144.03 25.78 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.504 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 8' ' ' LYS . 15.7 ptpt -86.12 113.49 22.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 110.966 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.37 -40.28 1.28 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.636 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -170.36 156.67 5.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.001 0.401 . . . . 0.0 110.552 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 30.9 m -78.48 162.18 26.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.846 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 9.2 mtmp? -81.54 141.38 33.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.723 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -54.51 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.96 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.79 -41.65 0.69 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 7.9 pt-20 -87.82 -176.31 5.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.641 0.258 . . . . 0.0 110.973 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.1 mmt-85 -132.63 144.78 50.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 111.304 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.485 HG13 HD12 ' A' ' 26' ' ' LEU . 25.1 t -73.3 139.5 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 32.1 mmt180 -118.77 -31.51 4.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.11 -143.62 5.84 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.828 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.754 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 7.3 p -136.62 148.26 47.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.647 0.224 . . . . 0.0 110.409 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 p -160.27 98.33 1.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.066 0.46 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.75 151.45 24.33 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.709 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 20.0 pt -59.0 122.47 9.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.663 0.231 . . . . 0.0 110.777 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.709 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 14.2 ptt-85 61.93 24.4 14.52 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.549 1.14 . . . . 0.0 111.734 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -126.11 140.37 52.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.926 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.3 pt? -126.39 153.06 45.48 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.442 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.15 121.8 24.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.19 139.37 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.852 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 84.8 m -133.11 124.94 18.72 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.89 147.21 84.8 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.045 2.497 . . . . 0.0 112.709 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -80.97 -41.0 23.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.116 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.491 -1.243 . . . . 0.0 108.471 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -161.18 153.87 20.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -160.09 123.76 3.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.6 m -150.66 143.29 24.48 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -153.86 160.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.096 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 73.8 m -88.05 110.64 20.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.996 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.57 134.76 15.11 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.59 118.48 23.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.854 0.359 . . . . 0.0 110.23 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' HA2' ' HG3' ' A' ' 24' ' ' ARG . . . 79.64 -41.2 2.31 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.957 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -175.09 144.68 0.76 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.765 0.282 . . . . 0.0 110.788 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 58.0 m -84.95 -178.54 6.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -81.69 142.43 32.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 -64.15 86.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.289 0.566 . . . . 0.0 111.166 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.83 -19.07 0.57 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 83.5 mt-10 -78.48 148.31 33.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.659 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -85.24 115.54 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.0 138.57 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.9 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.633 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 55.9 mtp85 -115.09 -43.56 3.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.785 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.88 -171.48 43.38 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.682 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 p -88.91 143.86 26.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.017 0.409 . . . . 0.0 110.899 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.8 p -145.39 44.4 1.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.296 0.57 . . . . 0.0 111.735 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.62 168.63 13.75 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 pt -63.91 109.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 110.098 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 11.0 tpt180 65.3 26.99 12.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.874 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 5.5 m-85 -113.15 135.12 54.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.182 0.515 . . . . 0.0 110.158 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -121.16 125.74 47.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.744 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 t80 -79.03 119.58 22.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -137.18 142.3 42.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 111.222 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 76.8 m -103.37 104.7 42.77 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 72.0 Cg_endo -81.93 138.47 10.37 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.574 2.183 . . . . 0.0 114.574 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.814 ' H ' ' HD3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.62 -19.45 32.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.971 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 16.7 ttm180 . . . . . 0 C--O 1.256 1.435 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.304 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 29' ' ' CYS . 24.6 tp -158.57 154.59 26.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -76.38 55.64 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.969 0.414 . . . . 0.0 111.538 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.2 m -78.69 137.38 37.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.122 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.84 160.27 27.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.152 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -80.52 117.16 21.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.193 0.521 . . . . 0.0 112.157 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.29 139.69 14.89 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.09 129.0 37.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.025 0.44 . . . . 0.0 110.023 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.68 -48.56 3.88 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.449 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.0 p80 179.27 160.4 0.72 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.801 0.3 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 163.18 25.68 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG3' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -94.14 153.25 18.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -49.71 108.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.09 -27.05 4.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.429 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.998 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 94.8 mt-10 -87.71 135.55 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.835 0.35 . . . . 0.0 110.613 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -91.94 125.76 36.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.089 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.25 134.98 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -110.61 -34.83 6.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.131 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.09 -152.48 14.87 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 17.4 p -118.62 138.8 52.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.047 0.424 . . . . 0.0 111.144 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -93.01 -37.13 12.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 110.279 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.02 14.84 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.63 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.48 114.87 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 111.504 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 63.44 21.78 12.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.723 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -127.94 136.64 51.61 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.146 0.498 . . . . 0.0 111.086 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.0 mp -128.54 147.2 50.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.353 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.95 122.84 27.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.48 136.46 54.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.976 0.417 . . . . 0.0 111.667 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.582 ' HB3' HD23 ' A' ' 2' ' ' LEU . 90.9 m -129.43 96.78 26.71 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.998 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 32.2 Cg_endo -63.6 156.95 53.96 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HE ' ' N ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -60.8 -20.46 61.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.404 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' N ' ' HE ' ' A' ' 31' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.945 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.92 138.49 48.16 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' CD1' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -77.82 145.95 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.958 0.409 . . . . 0.0 110.908 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.0 m -141.07 150.68 43.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.189 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.87 167.75 28.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 110.958 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 72.0 m -79.52 104.6 10.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.41 -178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.78 26.89 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -84.69 108.37 17.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.8 -40.71 1.4 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.43 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -167.67 163.61 14.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' GLU . 32.2 m -78.46 161.3 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.463 . . . . 0.0 110.522 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -93.51 157.94 15.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.265 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -52.52 120.32 5.48 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.04 10.19 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.524 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 1.012 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 78.5 mt-10 -86.49 130.73 34.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.708 0.289 . . . . 0.0 110.585 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.39 121.65 39.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.27 132.26 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.797 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -102.6 -43.37 5.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.113 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.41 -135.38 3.66 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 p -89.55 139.84 30.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.981 0.391 . . . . 0.0 110.823 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.21 -42.56 5.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.254 0.55 . . . . 0.0 110.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.75 21.39 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.8 pt -62.04 110.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.288 0.566 . . . . 0.0 110.912 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 59.87 27.97 17.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.199 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 25.9 m-85 -123.81 138.29 54.53 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.1 tp -99.66 136.7 39.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.806 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.05 114.31 19.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 61.1 m -123.22 135.78 54.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 111.739 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.3 m -128.57 100.61 21.9 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.197 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.012 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 43.4 Cg_endo -69.56 141.38 45.88 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.539 2.159 . . . . 0.0 113.646 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 31' ' ' ARG . 2.7 tpm_? -120.75 75.44 1.13 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.685 0.755 . . . . 0.0 109.989 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 32' ' ' ARG . 13.8 ttp85 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.749 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.827 HD23 ' H ' ' A' ' 2' ' ' LEU . 1.6 pt? -78.04 51.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 111.376 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.43 57.95 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.302 0.572 . . . . 0.0 109.934 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 56.6 m -67.38 139.84 57.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.017 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.01 174.88 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 95.6 m -83.07 112.54 19.89 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.51 130.87 9.99 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -74.4 101.39 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.834 0.35 . . . . 0.0 111.633 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.12 -32.62 0.93 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.718 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -167.15 151.56 6.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.928 0.364 . . . . 0.0 110.338 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 63.5 m -79.57 166.05 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.936 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -79.39 145.53 33.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.612 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -64.98 73.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.33 0.586 . . . . 0.0 111.341 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.12 -26.02 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.489 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HG3' ' HB3' ' A' ' 11' ' ' CYS . 1.7 pt-20 -99.32 157.35 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 111.271 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -93.63 137.13 33.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.875 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG22 ' SG ' ' A' ' 11' ' ' CYS . 37.4 t -82.69 118.94 31.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 46.0 tpt85 -89.94 -35.92 15.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.663 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.25 -137.22 4.74 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.678 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -90.88 142.35 27.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.52 0.2 . . . . 0.0 110.959 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.1 t -113.0 -40.64 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.127 0.489 . . . . 0.0 109.884 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.33 -157.85 17.71 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.0 pt -62.5 111.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.143 0.497 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 58.61 26.77 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.877 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 24.1 m-85 -124.04 137.3 54.6 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.082 0.468 . . . . 0.0 110.812 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -105.5 145.93 30.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.021 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -79.44 108.72 13.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 12.8 m -110.03 131.61 54.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.382 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -122.77 106.81 34.18 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 35.4 Cg_endo -66.69 143.65 68.79 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.148 2.565 . . . . 0.0 113.597 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 9.1 ttp180 -163.26 -38.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.579 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 51.3 mtp180 . . . . . 0 C--O 1.246 0.869 0 O-C-N 123.902 0.751 . . . . 0.0 110.08 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.3 tp -77.92 76.62 4.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.224 0.535 . . . . 0.0 110.102 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.606 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 5.0 tt -123.15 125.24 44.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.9 m -149.43 147.24 28.03 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.0 155.68 29.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.794 0.33 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.77 107.07 16.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.944 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.04 139.27 24.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -89.92 117.13 28.5 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.45 -43.78 2.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.608 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -165.68 146.75 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . 61.7 m -86.49 -163.85 0.96 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.602 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -79.85 149.89 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.624 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -67.25 117.78 9.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.43 1.07 60.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.035 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.655 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 5.5 tt0 -78.7 149.21 32.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.6 mmm-85 -98.23 121.1 39.75 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.176 -0.609 . . . . 0.0 111.549 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.9 t -71.4 138.11 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -111.45 -39.88 4.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.578 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.7 178.61 44.71 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -89.23 138.97 30.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.158 0.479 . . . . 0.0 110.891 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 67.7 m -92.76 -39.09 11.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.173 0.511 . . . . 0.0 110.071 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.8 -154.92 19.78 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.1 113.88 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.199 0.524 . . . . 0.0 111.233 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 64.57 21.47 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.725 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 3.8 m-85 -121.54 134.87 55.04 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.029 0.442 . . . . 0.0 111.006 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.3 tp -131.98 128.25 38.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.661 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 t80 -81.99 120.26 25.03 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 79.0 m -135.27 150.87 50.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 111.403 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.9 m -124.15 115.72 27.4 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.546 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 59.0 Cg_endo -80.54 139.55 12.81 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 113.847 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -81.06 -24.18 38.0 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 . . . . . 0 C--O 1.243 0.719 0 CA-C-N 114.328 -1.306 . . . . 0.0 107.802 179.261 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.0 mt -36.9 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.809 0.946 . . . . 0.0 112.808 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.14 63.81 2.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.617 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 62.9 m -56.68 137.05 54.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.634 -179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.95 164.44 34.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.4 t -79.36 103.4 9.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.798 0.332 . . . . 0.0 111.018 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.11 136.15 19.04 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -91.89 115.88 28.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.73 0.3 . . . . 0.0 111.096 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' A' ' 24' ' ' ARG . . . 75.76 -43.48 1.65 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.088 -0.577 . . . . 0.0 114.338 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -172.49 148.84 2.06 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.519 0.659 . . . . 0.0 111.317 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' A' ' 17' ' ' VAL . 35.4 m -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.457 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 56.5 tptt -79.17 134.94 36.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.398 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -58.38 97.8 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.941 0.4 . . . . 0.0 110.239 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.36 0.67 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 30' ' ' PRO . 15.9 pt-20 -86.86 167.38 14.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -112.39 133.97 54.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.513 HG22 ' SG ' ' A' ' 11' ' ' CYS . 36.3 t -73.11 131.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.102 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.581 ' HD2' ' HD2' ' A' ' 27' ' ' TYR . 58.9 ttm-85 -93.13 -38.03 11.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.918 0.389 . . . . 0.0 110.174 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.76 -160.64 28.07 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -89.71 142.81 27.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.743 0.306 . . . . 0.0 111.506 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.9 t -104.46 -42.65 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.031 0.443 . . . . 0.0 110.09 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.83 -152.53 11.38 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 pt -63.9 110.57 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 54.4 ttm-85 59.89 25.75 14.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.08 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -124.11 142.57 51.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.745 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 26' ' ' LEU . 2.2 pt? -140.52 147.9 40.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HD2' ' HD2' ' A' ' 18' ' ' ARG . 1.2 t80 -79.9 121.73 25.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 17.3 m -113.14 143.04 45.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.931 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -127.37 103.61 22.55 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.74 0.305 . . . . 0.0 110.242 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.698 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 42.0 Cg_endo -67.54 156.69 65.05 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.186 2.59 . . . . 0.0 112.41 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 tpp85 -78.43 55.73 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.646 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.725 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.2 mt 60.62 44.75 11.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.937 0.433 . . . . 0.0 111.482 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.84 140.59 36.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.469 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.49 145.5 55.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.281 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -151.4 165.79 33.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 93.5 m -85.79 106.67 17.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.941 0.4 . . . . 0.0 110.845 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -72.33 151.58 46.98 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.765 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -86.35 92.17 8.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.73 -38.61 1.93 Allowed Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.213 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -155.29 149.22 25.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.57 ' SG ' HG12 ' A' ' 17' ' ' VAL . 25.1 m -79.2 179.69 7.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.501 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -79.49 140.0 37.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -63.48 74.52 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.383 0.611 . . . . 0.0 111.845 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.75 -35.47 0.13 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.184 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 3.6 pt-20 -83.75 -178.33 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.881 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 15' ' ' GLU . 1.4 mpt_? -125.5 140.78 52.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 111.322 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG12 ' SG ' ' A' ' 11' ' ' CYS . 33.7 m -72.3 149.74 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.955 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 28.2 mmm180 -125.68 -33.17 2.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.61 -151.93 10.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.604 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 10.1 p -129.39 141.41 51.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.838 0.319 . . . . 0.0 110.715 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.725 ' HB2' ' HB3' ' A' ' 25' ' ' PHE . 63.3 m -97.29 -38.27 9.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.628 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.21 -154.89 22.45 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.053 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 17.2 pt -61.57 112.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.444 0.64 . . . . 0.0 111.063 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.9 mmt-85 64.5 31.7 12.25 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.168 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 41.5 m-85 -140.86 136.78 32.7 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.153 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.7 pt? -143.91 151.26 39.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.74 123.42 27.15 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.8 m -124.54 139.31 53.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 95.1 m -127.27 115.4 21.58 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 15' ' ' GLU . 6.0 Cg_exo -78.29 140.02 17.12 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.318 2.679 . . . . 0.0 111.441 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -116.82 -16.3 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.197 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 32' ' ' ARG . 3.5 ptm180 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 2' ' ' LEU . 1.6 pt? -65.75 113.48 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.02 0.438 . . . . 0.0 110.476 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 1.4 tm? -167.63 125.59 1.22 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 81.0 m -77.82 139.16 39.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.629 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -157.28 161.27 39.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.203 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 21.0 t -79.28 105.87 10.91 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.28 142.14 21.93 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.328 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -91.86 120.34 32.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.03 -52.27 2.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.385 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.32 155.28 0.5 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.202 0.501 . . . . 0.0 111.848 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.571 ' SG ' HD22 ' A' ' 26' ' ' LEU . 3.3 m -79.2 169.96 17.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.686 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.656 ' HG2' ' OE2' ' A' ' 15' ' ' GLU . 28.4 mmtt -81.61 160.85 23.69 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -66.84 72.19 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.006 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.39 -26.12 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.375 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.954 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.4 mt-10 -79.17 145.88 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.311 . . . . 0.0 110.384 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -83.62 125.62 32.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.011 HG23 HD21 ' A' ' 26' ' ' LEU . 3.7 p -76.47 132.96 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' A' ' 27' ' ' TYR . 27.0 mmm180 -113.03 -44.69 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.452 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.38 -145.95 10.26 Favored Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.378 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -107.02 143.01 35.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.018 0.409 . . . . 0.0 110.683 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 7.8 p -122.14 11.14 10.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 111.057 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.93 -173.5 36.62 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.616 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 pt -65.28 114.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 0.0 110.388 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 63.18 23.67 14.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.964 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 22.7 m-30 -115.14 138.36 50.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.345 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.011 HD21 HG23 ' A' ' 17' ' ' VAL . 5.4 tt -122.51 136.17 54.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.113 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 2.7 t80 -78.13 117.76 19.73 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 57.1 m -109.05 140.72 42.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.029 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.26 80.33 19.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.954 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 19.7 Cg_endo -57.73 151.47 55.5 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.9 2.4 . . . . 0.0 112.635 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 21.21 17.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.961 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.484 1.867 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 10.3 mp 70.83 149.57 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.066 0.509 . . . . 0.0 111.025 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.42 63.15 4.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 28' ' ' CYS . 48.7 m -66.14 137.45 57.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.591 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.94 160.82 40.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.789 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.41 118.32 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.078 0.466 . . . . 0.0 111.943 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 26' ' ' LEU . . . -90.04 154.8 24.0 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.377 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.61 108.73 19.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.636 0.255 . . . . 0.0 111.474 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.66 -40.32 0.95 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 114.384 0.514 . . . . 0.0 114.384 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.95 154.03 17.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.068 0.434 . . . . 0.0 110.919 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.6 m -79.12 161.96 26.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.087 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HD3' ' OE2' ' A' ' 15' ' ' GLU . 1.6 tttt -80.19 152.8 28.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.702 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -52.99 132.24 37.35 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.052 -179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 32' ' ' ARG . . . 100.6 -26.49 24.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.59 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.74 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 21.9 mt-10 -82.36 149.59 27.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -108.67 129.52 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 p -66.75 130.71 32.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.26 0.553 . . . . 0.0 110.933 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 27' ' ' TYR . 7.8 tpm_? -97.07 -40.91 8.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.87 -160.77 33.4 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.784 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.5 p -89.57 143.11 27.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.946 0.373 . . . . 0.0 111.363 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 52.3 t -110.33 -41.25 4.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.969 0.414 . . . . 0.0 110.29 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.99 -157.69 23.89 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.8 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.816 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -64.16 109.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.5 0.667 . . . . 0.0 110.542 179.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 62.51 30.5 17.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.059 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 29.1 m-85 -131.52 139.42 49.27 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.499 178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 7' ' ' GLY . 2.6 pt? -140.49 143.64 35.59 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' HB3' ' HB3' ' A' ' 18' ' ' ARG . 1.3 t80 -78.3 123.28 26.79 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 55.9 m -121.5 140.0 52.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.192 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -120.43 96.72 49.03 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 33.9 Cg_endo -66.5 135.09 37.94 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.732 2.288 . . . . 0.0 114.353 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 31' ' ' ARG . 27.4 tpt85 -119.85 -16.74 8.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.495 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 39.1 mmt180 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.19 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.7 mt 70.99 136.19 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 124.306 0.651 . . . . 0.0 111.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.1 60.94 4.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.747 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 36.0 m -62.58 138.45 58.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.307 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -158.98 163.26 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 70.0 m -91.75 107.93 19.55 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.873 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 148.24 40.46 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.073 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -83.84 108.72 17.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.632 0.253 . . . . 0.0 110.395 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.17 -43.16 1.72 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.865 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.09 142.06 3.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.582 0.229 . . . . 0.0 110.518 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.5 m -84.08 174.29 10.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.2 142.16 34.96 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.924 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -60.32 109.13 0.92 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.36 -26.61 2.28 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 1.017 ' HG2' ' HB3' ' A' ' 30' ' ' PRO . 41.4 mt-10 -78.8 139.16 38.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.269 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -82.95 97.9 8.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' SG ' ' A' ' 28' ' ' CYS . 39.4 t -60.92 127.89 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -95.88 -39.68 9.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.117 0.485 . . . . 0.0 109.728 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.9 -153.92 23.13 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.546 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -88.87 140.0 29.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.72 0.295 . . . . 0.0 111.042 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.3 t -93.87 -42.69 8.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.287 0.565 . . . . 0.0 110.004 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.21 -152.41 14.6 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 16.9 pt -58.6 116.05 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.775 0.287 . . . . 0.0 110.323 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 23' ' ' ILE . 15.4 ptm180 49.9 29.24 3.23 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 112.137 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 3.5 m-30 -122.45 137.89 54.72 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 21.7 tp -117.69 132.35 56.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.644 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.64 120.79 34.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 17' ' ' VAL . 56.5 m -137.03 154.3 50.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.034 0.445 . . . . 0.0 111.724 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 81.4 m -123.52 91.68 49.5 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.558 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.017 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 29.2 Cg_endo -64.4 138.41 60.21 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.496 2.131 . . . . 0.0 112.661 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -71.1 -67.64 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.755 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 32' ' ' ARG . 5.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.054 0.846 . . . . 0.0 111.528 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 29' ' ' CYS . 48.0 tp 74.62 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 110.623 -179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -162.92 78.2 0.46 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 32.5 m -60.93 138.91 58.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.063 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.75 157.31 43.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -85.97 115.48 23.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.468 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 11' ' ' CYS . . . -85.19 135.71 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -86.39 114.49 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.029 0.442 . . . . 0.0 110.38 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.82 -47.52 3.69 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.061 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 p80 179.58 137.58 0.11 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.397 . . . . 0.0 110.301 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 7' ' ' GLY . 38.4 m -80.2 -154.47 0.1 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 10.1 mmpt? -106.39 152.31 23.76 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -68.36 63.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.799 0.809 . . . . 0.0 110.558 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.78 -35.77 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.371 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.887 ' HG3' ' HB3' ' A' ' 30' ' ' PRO . 2.4 mp0 -79.9 138.3 37.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.061 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -85.47 128.03 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 127.62 30.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.291 0.567 . . . . 0.0 110.606 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -103.36 -33.98 8.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.059 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.63 -152.78 20.4 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . 14.1 p -116.43 139.74 50.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.848 0.324 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.1 m -92.57 -38.49 11.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.01 -153.99 14.16 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.793 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 pt -59.25 113.06 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.57 . . . . 0.0 111.628 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 60.91 27.1 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.244 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.34 136.0 49.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.817 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 7.3 mp -125.48 142.02 51.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -83.75 121.48 27.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 70.1 m -127.17 135.04 50.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 111.689 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 72.9 m -110.15 104.21 55.22 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.769 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.887 ' HB3' ' HG3' ' A' ' 15' ' ' GLU . 72.8 Cg_endo -76.6 146.45 27.16 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.908 2.405 . . . . 0.0 114.038 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.35 57.69 4.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.956 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 3.2 tpm_? . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.521 179.87 . . . . . . . . 1 1 . 1 stop_ save_